Age-related differences in stress response: Increase markers for oxidative stress and liver damage after heat stress in aged rats? by Wagner, Cornelia
 Aus der Berufsgenossenschaftlichen Unfallklinik Tübingen 
Klinik für Unfall- und Wiederherstellungschirurgie an der 
Universität Tübingen 
 
 
Age-related differences in stress response: 
Increase markers for oxidative stress and liver damage 
after heat stress in aged rats? 
 
 
Inaugural-Dissertation 
zur Erlangung des Doktorgrades  
der Medizin 
 
 
 
 
der Medizinischen Fakultät 
der Eberhard Karls Universität 
zu Tübingen 
 
 
 
 
 
vorgelegt von 
 
 
Wagner, Cornelia  
 
 
 
 
 
 
2017 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dekan:    Professor Dr. I. B. Autenrieth 
1. Berichterstatter:  Professor Dr. A. K. Nüssler 
2. Berichterstatter:  Privatdozent Dr. M. Schenk 
 
Tag der Disputation: 20.04.2017  
I 
 
Contents 
Contents …………………………………………………………………I 
Index of figures and tables .......................................................... III 
List of figures .................................................................................................. III 
List of tables ................................................................................................... IV 
Nomenclature ................................................................................ V 
1. Introduction ................................................................................ 1 
1.1. Aging and age-related diseases .............................................................. 1 
1.2. Oxidative stress, reactive oxygen species and mitochondria ................... 5 
1.3. Lipid peroxidation ................................................................................... 13 
1.4. Oxidative stress-induced liver damage .................................................. 17 
1.5. Heat stress in aging ............................................................................... 19 
1.6. BMBF joint research project OXISYS .................................................... 22 
1.7. Aim of the project ................................................................................... 23 
2. Materials and Methods ............................................................ 25 
2.1. Materials ................................................................................................ 25 
2.1.1. Chemicals 25 
2.1.2. Equipment 26 
2.1.3. Animals 27 
2.1.4. Heat stress experiments 28  
2.2. Methods ................................................................................................. 29 
2.2.1. Human serum for preliminary experiments 29 
2.2.2. Isolation of cytosol from liver tissue 29 
2.2.3. Lowry protein assay 30 
2.2.4. Lactate dehydrogenase activity assay 31 
2.2.5. Alanine-aminotransferase activity assay 32 
2.2.6. Malondialdehyde assay 34 
2.2.7. 4-Hydroxynonenal ELISA 36 
2.2.8. H&E-staining of liver sections 37 
2.2.9. Statistical analysis 38 
II 
 
3. Results ...................................................................................... 39 
3.1. Human serum for preliminary experiments ............................................ 39 
3.2. H&E-staining of liver sections ................................................................ 40 
3.3. Serum and liver tissue of untreated rats ................................................ 43 
3.3.1. Protein content 43 
3.3.2. Markers for cell damage 44 
3.3.3. Lipid peroxidation marker 45 
3.4. Serum and liver tissue after the heat stress ........................................... 47 
3.4.1. Protein content 47 
3.4.2. Markers for cell damage 48 
3.4.3. Lipid peroxidation marker 50 
4. Discussion ................................................................................ 54 
4.1. Review of current studies ....................................................................... 54 
4.2. Limitations of methods ........................................................................... 61 
4.3. Conclusion ............................................................................................. 63 
5. Abstract .................................................................................... 65 
6. Zusammenfassung .................................................................. 66 
7. References ............................................................................... 68 
8. Appendix .................................................................................. 81 
9. Erklärung zum Eigenanteil ...................................................... 84 
10. Publication ............................................................................. 85 
11. Acknowledgements ............................................................... 86 
12. Lebenslauf ............................................................................. 87 
 
III 
 
Index of figures and tables 
List of figures 
Figure 1: Population pyramid of Germany from 1950 (left) and 2015 (right). ............................... 1 
Figure 2: Universal traits of aging (left) and age-related diseases (right). .................................... 5 
Figure 3: Sources and functions of ROS. ...................................................................................... 7 
Figure 4: ROS generation in mitochondria and their metabolism inside cells. ............................. 9 
Figure 5: Mitochondrial ROS production and harmful effects of ROS. ....................................... 11 
Figure 6: Scavenging reactions of antioxidative enzymes. ......................................................... 12 
Figure 7: Process of lipid peroxidation. ....................................................................................... 15 
Figure 8: Formation of MDA and 4-HNE as end-products of lipid peroxidation. ......................... 17 
Figure 9: Oxidative stress in the liver causing liver diseases. ..................................................... 18 
Figure 10: Age-related changes in heat stress conditions. ......................................................... 20 
Figure 11: Schematic diagram of HSP synthesis. ....................................................................... 22 
Figure 12: Structure of joint research project OXISYS................................................................ 23 
Figure 13: Overview of untreated control group. ......................................................................... 27 
Figure 14: Overview of middle-aged and old rats after heat stress. ........................................... 29 
Figure 15: Lowry protein assay reactions step by step. .............................................................. 30 
Figure 16: Principle of LDH activity assay. .................................................................................. 31 
Figure 17: Formula for calculation of LDH activity. ..................................................................... 32 
Figure 18: Principle of ALT activity assay. .................................................................................. 33 
Figure 19: Formula for calculation of ALT activity. ...................................................................... 33 
Figure 20: Principle of TBA-method for determination of MDA level in serum and liver tissue. . 34 
Figure 21: Principle of 4-HNE Sandwich ELISA method. ........................................................... 36 
Figure 22: LDH, ALT and c(MDA) in human serum of young and old individuals. ..................... 40 
Figure 23: H&E-stained liver sections of young, middle-aged and old untreated rats. ............... 41 
Figure 24: H&E-stained liver sections of middle-aged and old rats at different points in time  
(0 h, 2 h, 6 h, 24 h) after heat stress. .......................................................................................... 43 
Figure 25: Protein mass concentration [mg/ml] in young, middle-aged and old untreated rats. . 43 
Figure 26: LDH activities in serum [U/l] and liver tissue [mU/mg] of young, middle-aged and  
old untreated rats. ....................................................................................................................... 44 
Figure 27: ALT activities [U/l] in serum of young, middle-aged and old untreated rats. ............. 45 
Figure 28: c(MDA) in serum [nmol/ml] and liver tissue [nmol/mg] of young, middle-aged and  
old untreated rats. ....................................................................................................................... 46 
Figure 29: c(4-HNE) [ng/mg] in liver tissue of young, middle-aged and old untreated rats. ....... 47 
Figure 30: Protein mass concentration [mg/ml] in serum and liver tissue of untreated and  
heat-stressed middle-aged and old rats. ..................................................................................... 48 
IV 
 
Figure 31: LDH activities [U/l] in serum of untreated and heat-stressed middle-aged and  
old rats. ........................................................................................................................................ 49 
Figure 32: LDH activities [mU/mg] in liver tissue of untreated and heat-stressed middle-aged 
and old rats. ................................................................................................................................. 49 
Figure 33: ALT activities [U/l] in the serum of untreated and heat-stressed middle-aged and 
 old rats. ....................................................................................................................................... 50 
Figure 34: c(MDA) [nmol/ml] in serum of untreated and heat-stressed middle-aged and  
old rats. ........................................................................................................................................ 51 
Figure 35: c(MDA) [nmol/mg] in liver tissue of untreated and heat-stressed middle-aged and  
old rats. ........................................................................................................................................ 52 
Figure 36: c(4-HNE) [ng/mg] in liver tissue of untreated and heat-stressed middle-aged and 
old rats. ........................................................................................................................................ 53 
Figure 37: Decision tree for measuring oxidant status in clinical tissue...................................... 83 
List of tables 
Table 1: List of used solutions, solids and buffers. ..................................................................... 25 
Table 2: List of used equipment. ................................................................................................. 26 
Table 3: BSA standard curve mass concentrations. ................................................................... 31 
Table 4: Standard curve for TBA-Method generated as two-fold dilution series. ....................... 35 
Table 5: Standard curve for 4-HNE ELISA generated as two-fold dilution series. ...................... 37 
Table 6: Serum levels of LDH, ALT and MDA in serum of young and old patients. ................... 40 
Table 7: Protein content, LDH, ALT and MDA in human serum for preliminary experiments. ... 81 
Table 8: Protein content, LDH, ALT, MDA and 4-HNE in serum and liver tissue of young, 
middle-aged and old untreated rats. ........................................................................................... 81 
Table 9: Protein content, LDH, ALT, MDA and 4-HNE in serum and liver tissue of middle-aged 
heat-stressed rats at four points in time. ..................................................................................... 82 
Table 10: Protein content, LDH, ALT, MDA and 4-HNE in serum and liver tissue of old         
heat-stressed rats at four points in time. ..................................................................................... 82 
 
 
V 
 
Nomenclature 
4-HNE   4-hydroxynonenal 
8-OHdG   8-hydroxydesoxyguanosin 
AIF   apoptosis inducing factor 
ALD   alcohol-induced liver disease 
ALT   alanine-aminotransferase enzyme 
BMBF   Federal Ministry of Education and Research 
BSA   bovine serum albumin 
CAT   catalase 
CCl4   carbon tetrachloride 
CR   caloric restriction 
Cu2+   copper ion 
CYP2E1   cytochrome P450 2E1 
ELISA   enzyme-linked immunosorbent assay 
GC   gas chromatography 
GPx   glutathione peroxidase 
GR   glutathione reductase 
GSH   glutathione 
GSSG   glutathione disulfide 
H&E-staining   Hematoxylin & Eosin-staining 
H2O2   hydrogen peroxide 
HCC   hepatocellular carcinoma 
HPC   heat stress preconditioning 
HPLC   high performance liquid chromatography 
HRP   horseradish peroxidase 
HSF   heat stress transcription factor 
HSP   heat shock proteins 
IPC   ischemic preconditioning 
LDH   lactate dehydrogenase enzyme 
LPO   lipid peroxidation 
MDA   malondialdehyde 
MLS   maximum life span 
VI 
 
MS   mass spectrometry 
mtDNA   mitochondrial DNA 
O2   singlet oxygen 
O2-•   superoxide anion 
OH•   hydroxyl radical  
PUFA   polyunsaturated fatty acid 
PTP   permeability transition pore 
ROS   reactive oxygen species 
SD   standard deviation 
SOD   superoxide dismutase 
TBA   thiobarbituric acid 
TBARS   thiobarbituric acid reactive substances 
TEP   tetraehtoxypropane 
 
1 
 
1. Introduction  
1.1. Aging and age-related diseases 
The process of aging affects every living creature on the planet and the death 
stands inevitably at the end of life. Since generations scientists try to find a way 
to encode and prevent the deleterious process. The aging of an organism is 
defined as a progressive decline of physiological functions with increased 
probability for disease and death within life span (Harman, 2003, Droge, 2002). 
The life expectancy of human beings has been constantly changing over the 
centuries. The number of people aged over 45 years is increasing, especially in 
the developed countries. In Germany as a developed country the shift towards 
an overaged population is clearly observed. By comparing the population 
pyramids of 1950 and 2015, the progressive change from 1950’s clock-model 
with a large base of people under 30 years to an onion-shaped model in 2015 
displaying a major group of people over 45 years is visible (Figure 1). This trend 
appears in both sexes as well as in other developed countries and even in 
underdeveloped countries (Nations, 2015). 
 
Figure 1: Population pyramid of Germany from 1950 (left) and 2015 (right). Age distribution 
of males and females in 1950 is compared to 2015 visualizing the overaging of the population. 
[adopted from (Nations, 2015)] 
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During the last centuries the life expectancy of people has increased due to less 
infant mortality and improved health care conditions including treatment for 
infections and better management of chronic diseases and cancer (Mathers et 
al., 2015). Life expectancy is defined as the average life time that an individual in 
a certain environment will survive (Tosato et al., 2007). Aims concerning 
extended life expectancy are described as healthy longevity including 
maintenance of functional capacity up to an old age (Jin et al., 2015). Another 
view on the process of aging is the evaluation of the maximum life span defined 
as the maximum number of years that a human being can reach. The maximum 
life span of humans with a total of 125 years has not changed for 100.000 years 
and different approaches are made trying to explain how we age and why 
(Hayflick, 2000). It is hypothesized that different interacting factors exist that lead 
to aging of an organism (Cui et al., 2012). By observing epidemiological factors 
of a population such as mortality and morbidity, scientists were early trying to 
identify the “perfect survival conditions” for human beings but an explanation for 
the cause of aging is still missing (Ferrucci et al., 2008). With increased 
knowledge about molecular pathways, the theory of the accumulation of cellular 
damage as major cause for aging over time was developed (Gems and Partridge, 
2013, Vijg and Campisi, 2008, Kirkwood, 2008). An increasing risk for protein, 
lipid and DNA damage as well as altered intracellular signal pathways and 
ineffective removal of damaged cells was identified in elderly individuals (López-
Otín et al., 2013).  
This thesis focuses on the understanding of accumulated oxidative cell damage 
in aging and age-related molecular changes in an organism. The degenerative 
aging process is characterized by a variety of universal traits such as impaired 
wound healing, poor vision and reduced hearing but it is also closely linked to 
certain diseases (Figure 2). It alters the function and structural integrity of the cell 
and weakens their regeneration abilities with increasing the risk for diseases 
mainly affecting the immune system, the central nervous system, the 
cardiovascular system and the liver (Poulose and Raju, 2014). The risk to suffer 
from Type 2 diabetes known as non-insulin-dependent diabetes increases 
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dramatically in age and up to 70% of patients with Type 2 diabetes are older than 
55 years (Nathan et al., 1986).  
In aged individuals different cells of the immune system are influenced in their 
function leading to a dysfunctional immune response. This increases the 
probability of infectious diseases like pneumonia and influenza, autoimmune 
disorders and cancer (Hawkley and Cacioppo, 2004, Castle, 2000). The acquired 
cell-mediated immunity is mainly affected by aging as the T-cell maturation and 
selection in the thymus is decreased. It is linked to the age-dependent involution 
of the thymus that is finally completed around the age of 60 (Gui et al., 2012, 
Grubeck-Loebenstein, 1997). It has been demonstrated that the amount of naïve 
T-cell production declines with an increase of memory T-cells. T-cell mediated 
signal cascades are altered weakening the specific immune protection against 
pathogens (Miller, 1996). The altered immune response is closely linked to 
malignant degeneration of cells. Certain types of neoplasm show a higher 
incidence in older people mainly affecting prostate gland, colon and breast tissue 
(Suen et al., 1974). Cancerous cells share similarities including cellular 
transformation, dysregulated apoptosis, uncontrolled cell proliferation and 
metastasis (Vasto et al., 2009). One explanation of the age-dependency of 
neoplasm is the increase of DNA mutations due to the cumulative exposure 
towards oxidative stress (DePinho, 2000). But also inefficient apoptosis in elderly 
people, normally useful to regulate the number of cells in tissues, enables the 
uncontrolled proliferation of cancerous cells increasing the resistance against 
their removal (Lowe and Lin, 2000).  
Other age-dependent diseases are neurodegenerative diseases including 
Alzheimer’s disease and Parkinson’s disease that show a significantly increased 
incidence in older individuals (Schon and Przedborski, 2011). It is difficult to 
identify proper causes for brain aging in healthy elderly as diseases mainly 
contribute to the decline in cognitive function in aged individuals (Glorioso and 
Sibille, 2011). Properties of neurodegenerative diseases were also found in 
‘healthy’ aged people and the theory of oxidative damage during aging develops 
with an accumulation of dysfunctional cells. The tissue of central nervous system 
can be characterized by a high metabolic rate, oxygen consumption and lipid 
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content making it more susceptible towards oxidative damage compared to other 
tissues (Kumar et al., 2012). Additionally, nervous cells contain mainly post-
mitotic cells without further ability to divide and regenerate causing more severe 
damage in tissues compared to cells with a high turnover rate (Di Domenico et 
al., 2016). Patients suffering from Alzheimer’s disease have shown increased 
rates of oxidized proteins underlining this theory (Smith et al., 1991).  
Over many years diseases of the cardiovascular system remain the main cause 
of death in industrial countries with an increased risk in elderly for myocardial 
ischemia following arteriosclerosis and congestive heart failure (Sistino, 2003). 
Constitutional differences of the heart with advancing age could be identified even 
in apparently healthy elderly including increase in heart weight as a sign for left 
ventricular hypertrophy as well as altered diastolic filling periods (Fleg and Strait, 
2012). Also the peripheral vascular system is affected as arteries elongate and 
the vascular wall gets more rigid due to structural changes and less elastic 
components (Lee and Oh, 2010). These are signs of early arteriosclerosis that in 
the final state includes focal lesions, stenosis of vessels and plaque formation 
(Ferrari et al., 2003). Both the brain and the heart are organs with a high metabolic 
rate that processes large amounts of oxygen (Dai et al., 2012). Therefore, the 
heart is prone to severe accumulation of oxidative damage and of special interest 
in determining an increase oxidative status in older individuals. Increased 
oxidative stress status was evaluated in the pathogenesis of arteriosclerosis 
(Mashima et al., 2001) as well as in patients suffering from congestive heart 
failure (Belch et al., 1991) and myocardial ischemia (Rodrigo et al., 2013).  
Finally, the liver as a model organ in this study is known to be less affected by 
the aging process compared to other high-blood-flown organs like heart and 
brain. It has a high regenerative capacity and therefore is widely studied in the 
field of oxidative damage (Schmucker, 1998). The liver fulfills numerous functions 
that can be basically summed up as the ability to excrete harmful substances 
such as toxins and drugs, containing parts of carbohydrate, protein and lipid 
metabolism and the secretion of bile produced in the hepatocytes into the bile 
duct (Mangoni and Jackson, 2004, Mitra and Metcalf, 2009). With advancing age, 
the liver undergoes various changes with a loss of hepatic volume up to 20-40% 
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and reduced blood flow through the liver of up to 35-40% (Zeeh and Platt, 2002, 
Grizzi et al., 2013). This could be responsible for the reduced drug elimination 
rate in elderly leading to an altered metabolism for drugs and toxins. Further bile 
synthesis and secretion is halved indicating reduced transport mechanisms in 
aging (Zeeh and Platt, 2002). Finally, the regeneration capacity defined as loss 
of hepatic function declines and old individuals need more time to restore liver 
function after damage (Sanz et al., 1999).  
 
Figure 2: Universal traits of aging (left) and age-related diseases (right). Various general 
aging traits are identified monitoring the aging process including hearing loss, wrinkled skin, 
reduced vision and gray hair. Immune system response is weakened as well as wound healing. 
Age-related diseases interact with aging and display possible cellular alterations [modified from 
(Naylor et al., 2013)]. 
1.2. Oxidative stress, reactive oxygen species and mitochondria 
One of the first biochemical models that links the process of aging and the 
accumulation of oxidative damage in an organism is the ‘free radical theory of 
aging’ of Denham Harman 50 years ago. According to Harman the impact of 
negative effects on the cell defined as free radicals could weaken their ability to 
react to certain levels of ‘stress’ (Harman, 1956). The accumulation of radicals 
inside the cell leads to further damage and finally cell death (Tosato et al., 2007). 
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The oxygen metabolism is identified as a major cause for the generation of 
radicals inside cells (Halliwell and Gutteridge, 2007). In an aerobic environment 
the oxygen is mainly processed into water in the respiratory chain of mitochondria 
producing ATP but small amounts of oxygen (up to 4%) are converted into oxygen 
radicals (Farber, 1994). These so-called reactive oxygen species (ROS) can 
accumulate during aging inside cells and alter the cells metabolism (Masoro, 
2005). The imbalance that occurs between ROS formation and protection 
mechanisms of the cell with favor to the radical site is defined as oxidative stress 
(Sies, 1993). This could be caused either by an increased production of radicals 
or a decreased protection against radicals (Davies, 2000). Protection 
mechanisms were identified to extend the life span as the overexpression of 
genes encoding for elimination of radicals in the fruit fly Drosophila melanogaster 
was found to significantly increase the maximum life span, whereas the 
inactivation of protection mechanisms in the mouse is neonatal lethal (Melov, 
2000). Controversial effects concerning radical formation and possible oxidative 
tissue injury have been described and physiological ROS levels are found to 
trigger signal transduction pathways (Halliwell and Gutteridge, 2007). The 
oxidative modification of kinases, phosphatases and transcription factors 
resulting in their activation regulates physiological functions inside cells as well 
as the ability to react towards stress (Hekimi et al., 2011) (Figure 3). ROS 
enhance signal cascades but it is also necessary to finally end the triggered 
signal. Therefore, it is essential for proper physiological responses to keep the 
sensitive balance between positive oxidative enforcement of signal cascades and 
reducing conditions for their termination (Droge, 2002). This so-called positive 
oxidative stress enables the adaptation of an organism to stressful conditions 
such as hypo-and hyperthermia, hypoxia and ischemia (Yan, 2014, Lu et al., 
2014, Salido et al., 2013). Further studies have shown that ischemic tolerance 
after preconditioning was found to increase the protection of tissue against 
ischemic-induced injury (Eipel et al., 2005, Glanemann et al., 2004, Mori et al., 
2000). However, by passing a sensitive threshold at higher levels ROS target 
different macromolecules of the cell mainly including proteins, nucleic acids and 
lipids. During aging this oxidative damage of macromolecules accumulates as 
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repair processes slow down and detection mechanisms decline leading to 
dysfunctional cells (Kumar et al., 2012). There are different techniques to 
determine the grade of oxidative stress in body fluids and tissues. The oxidation 
of proteins is measured as cross-linked protein aggregates (Stadtman, 2001). 
Alteration in nucleic acid include DNA strand breaks and base modifications 
which affect the genome stability and result in an increased rate of mutations 
(Mecocci et al., 1993) and the oxidation of lipids which initiates the chain reaction 
of lipid peroxidation with increased end-products indicate higher levels of 
oxidative stress (Niki, 2009).  
 
Figure 3: Sources and functions of ROS. Reactive oxygen species (ROS) generated in the 
mitochondria or at other sites fulfill two main functions in cell metabolism. At lower levels ROS 
serve as second messenger molecules and modulate important pathways but at higher levels 
they damage macromolecules including lipids, DNA and proteins. Antioxidants control the ROS 
generation, stop signal cascades and keep the redox balance [modified from (Hekimi et al., 
2011)]. 
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Reactive oxygen species (ROS) and mitochondria 
ROS are generated in an organism from endogenous and exogenous sources. 
The main endogenous source is the respiratory chain of mitochondria but also 
enzymes like NADPH oxidases, lipoxygenases and cytochrome P450 can 
generate ROS (Finkel and Holbrook, 2000). Aging was found to increase the 
release of ROS from the respiratory chain and less energy in form of ATP is 
produced emphasizing the major impact of mitochondrial oxidative damage 
during aging (Moghaddas et al., 2003, Sastre et al., 2000). Exogenous sources 
are ionizing radiation and ultraviolet light as well as toxins and chemotherapeutics 
(Kudryavtseva et al., 2016). ROS include free radicals like superoxide anion (O2-
•) and hydroxyl radical (OH•) as well as non-radicals like hydrogen peroxide 
(H2O2) and singlet oxygen (O2). They contain one or more unpaired electrons that 
make them highly reactive to other molecules (Shah et al., 2014, Ozcan and 
Ogun, 2015). ROS convert into stabilized molecules by stealing electrons from 
other nearby structures initiating the creation of more radicals or reacting with 
each other forming a stable end-product (Lee et al., 2004). O2-• is mainly 
generated in the respiratory chain of mitochondria that is located at foldings of 
the inner membrane. It consists of complex I-IV that build up an ionic gradient to 
enable energy production via ATP synthase (Figure 4A). During reactions, 
constantly O2-• leaks into the mitochondrial matrix as well as into the 
intermembrane space potentially damaging nearby macromolecules. Especially 
mitochondrial DNA (mtDNA), membrane lipids and proteins are vulnerable to 
ROS-mediated lesions leading to mitochondrial dysfunction with higher 
production of ROS and increased apoptosis. 
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Figure 4: ROS generation in mitochondria and their metabolism inside cells. A Mitochondrial 
respiratory chain at the inner membrane consists of complex I-IV that build up a proton gradient 
(H+) to generate energy via the ATP synthase. Superoxide anions (O2-•) leak in the matrix and in 
the intermembrane space. B ROS (O2-•, H2O2, OH•) metabolism inside cells. O2-• is processed 
via superoxide dismutase (SOD) into H2O2 and catalase as well as glutathione system buffers 
H2O2 into water. H2O2 can react with Fe2+ via Fenton reaction forming OH• [adopted from 
(Bigarella et al., 2014)]. 
O2-• is removed by the enzyme superoxide dismutase (SOD) creating oxygen and 
H2O2 (Figure 4B). H2O2 is a by-product of many reactions in the organism and 
can be decomposed in the presence of reduced iron ions either into highly 
dangerous OH• via Fenton reaction (Fe2+ + H2O2 ↔ Fe3+ + OH + OH•) (Cheng et 
al., 2002) or it is buffered by catalase (CAT) into water and oxygen (Slimen et al., 
2014). H2O2 also targets distant cells as it can diffuse through membranes and 
has a relatively long half-life (Cadenas and Davies, 2000). OH• generated from 
H2O2 is known as the most damaging radical due to its extreme reactivity and 
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short half-life making it mainly responsible for nearby oxidative damage to DNA 
molecules such as base modifications and strand breaks (Zorov et al., 2014). 
OH• reacts with the guanosine base of DNA and forms 8-hydroxydesoxyguanosin 
(8-OHdG) that is found to increase in relation to oxidative stress (Haghdoost et 
al., 2005). It has been shown that mutations in mtDNA are 10 times higher 
compared to chromosomal DNA (Mecocci et al., 1993). In comparison to the 
nuclear DNA, mtDNA is not covered by histone proteins, has a high transcription 
rate and is located near the site of ROS production that makes them more 
susceptible for oxidative injury (Cai et al., 1998). With increasing age and 
accumulation of mtDNA damage the respiratory chain produces more ROS finally 
increasing the risk for diseases and enforcing the aging process (Van Remmen 
and Richardson, 2001).  
Mitochondrial oxidative damage also increases the release of intermembrane 
space proteins into cytoplasm such as cytochrome c by making the outer 
membrane more permeable for these substances (Figure 5) (Murphy, 2009, 
Gellerich et al., 2000). Cytochrome c is part of the respiratory chain transferring 
electrons and when released out of the intermembrane space into cytoplasm it 
serves as a signaling molecule that activates a chain of caspases that finally 
induce apoptosis (Cai et al., 1998). Additionally, the formation of a permeability 
transition pore (PTP) in the inner membrane causes rapid movement of ions that 
lead to mitochondrial swelling and loss of mitochondrial membrane potential. This 
allows small molecules like the apoptosis-inducing factor (AIF) to be released 
more easily into cytoplasm inducing apoptosis (Murphy, 2009, Cai et al., 1998). 
Furthermore lipid peroxidation of the mitochondrial membrane as well as 
oxidization of mtDNA is induced making mitochondria more vulnerable and 
further affect the functionality of the respiratory chain (Sastre et al., 2003).  
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Figure 5: Mitochondrial ROS production and harmful effects of ROS. Mitochondrial ROS are 
produced in the respiratory chain at the inner membrane. ROS damage directly membranes via 
lipid peroxidation, attack mtDNA and alter the functionality of mitochondrial membranes. Outer 
membrane permeability (MOMP) is increased as well as opening permeability transition pore 
(PTP) leading to increased apoptosis and necrosis [adopted from (Murphy, 2009)]. 
Protection against oxidative stress 
Organisms can react to increasing oxidative stress by upregulating certain 
protecting molecules such as antioxidative enzymes and non-enzymatic 
antioxidants that can buffer the ROS (Davies, 2000, Mezzetti et al., 1996). The 
antioxidant system consists of enzymes including superoxide dismutase (SOD), 
catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR) and 
non-enzymatic molecules such as vitamin E and glutathione (GSH) (Finkel and 
Holbrook, 2000, Yu, 1994, Lee et al., 2004). McCord and Fridovich discovered in 
1969 the role of SOD as an enzyme scavenger protecting tissue against oxidative 
damage (McCord and Edeas, 2005, McCord, 1974). In humans exist three forms 
of SOD: cytoplasmic Cu/ZnSOD, mitochondrial MnSOD and extracellular SOD 
(Matés et al., 1999). All SOD forms have transition metals at their active side 
including copper, magnesium and zinc that are oxidized or reduced while SOD is 
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detoxifying O2-• (Davies, 2000). SOD activity in erythrocytes of healthy humans 
was found to decrease during aging drawing a link to oxidative injury as radicals 
could not be buffered effectively (İnal et al., 2001). SOD converts O2-• into oxygen 
and H2O2 which is further processed by CAT into water and oxygen (Figure 6). 
The glutathione redox system consists of GPx that also detoxifies H2O2 by 
oxidizing GSH to glutathione disulfide (GSSG) into water (Tian et al., 1998). GR 
is necessary to re-reduce GSSG into 2 molecules of GSH by oxidizing NADH to 
NAD+ (Circu and Aw, 2010). GSH mainly synthesized in the liver is not only 
substrate for GPx but also antioxidative molecule itself as it buffers OH• and 
singlet oxygen (Sies, 1999). Another defense mechanism of the cell is the ability 
to undergo apoptosis instead of ending up with uncontrolled necrosis harming 
surrounding cells with a secondary stress. During apoptosis the cell is engulfed 
by phagocytes to prevent an immune reaction and re-use valuable nutrients 
(Davies, 2000). It is controversial discussed whether increased antioxidative 
capacity would increase life span as low levels of ROS serve as signaling 
molecules and former studies have shown that the excessive intake of 
antioxidants has severe side effects with increased mortality and even induction 
of cancer (Bjelakovic et al., 2004, Miller et al., 2005, Vivekananthan et al., 2003). 
Higher antioxidant levels can protect from oxidative damage but they also reduce 
the physiological adaptation of the cell towards stress that is necessary for 
metabolic pathways (Sena and Chandel, 2012). 
 
Figure 6: Scavenging reactions of antioxidative enzymes. Removal mechanisms for O2-• and 
H2O2 are schematically shown. SOD converts O2-• into O2 and H2O2 and CAT further detoxifies 
H2O2 into H2O and O2. The glutathione redox system consists of GPx that transforms H2O2 into 
water by oxidizing 2 GSH into GSSG. GSSG is reduced into GSH by GR to form new substrate 
[adopted from (Peng et al., 2014)]. 
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1.3. Lipid peroxidation  
The oxidative stress in form of ROS leads via a chain reaction that is called lipid 
peroxidation (LPO) to altered structure and function of lipids mainly in cell 
membranes (Kudryavtseva et al., 2016, Yu, 1994). To evaluate a possible 
oxidative damage, the amount of LPO is found to be significantly increased in 
stressful conditions. Lipids are made up of fatty acid chains with a carbon 
backbone mainly consisting of 14 to 24 carbon atoms that could be categorized 
into saturated or mono- and polyunsaturated fatty acids. Polyunsaturated fatty 
acids (PUFA) contain two or more carbon-carbon double bonds that weaken 
nearby carbon-hydrogen bonds and make them more susceptible for radical 
attacks because they more easily split off hydrogen atoms (Farber, 1994).  
Membranes of aged individuals show an increased amount of long-chain PUFA 
that are more prone to peroxidation creating protein cross-links that increase the 
rigidity of membranes and make the membrane more vulnerable to oxidative 
stress (Laganiere and Yu, 1993). Previous studies have shown that short-living 
species like rats with maximum life span (MLS) of 4 years have more PUFA with 
higher numbers of double bonds that are more easily attacked by ROS in 
comparison to long-living species such as horses (MLS = 46 years) (Pamplona 
et al., 2000). Also naked mole-rats (MLS = 28 years) in comparison to mice (MLS 
= 3-4 years) have less PUFA that are highly affected by LPO underlining the 
theory that membrane composition has influence on the longevity of species 
(Hulbert et al., 2006). So long-living species show a decreased rate of 
unsaturation due to lower levels of highly reactive PUFA in membranes that 
decreases their sensitivity towards LPO and therefore fewer harmful products 
that damage cells are produced (Naudí et al., 2013).  
Cell membranes work as selective barriers protecting the cell, support vital 
functions in signaling pathways and are composed of a phospholipid bilayer (30-
80%) including proteins (20-60%) and some carbohydrates (0-10%) (Catalá, 
2009). The high amount of PUFA in phospholipids of cell membranes are priority 
targets for LPO (Farber, 1994). Especially phospholipids located in the 
mitochondrial membrane are affected due to their near-by location to the 
respiratory chain (Andziak and Buffenstein, 2006). The membrane proteins can 
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be either located at the inner or outer part of the membrane as well as traversing 
the membrane. Together they create a so-called Fluid Mosaic Model, a two-
dimensional fluid model of orientated proteins and lipids that allows molecules to 
move in the plane of the membrane (Nicolson, 2014). This is essential for the 
cellular function. Oxidative damage via LPO was found to affect the membrane 
fluidity and permeability for certain molecules leading to disturbed metabolic 
processes (Andziak and Buffenstein, 2006). The oxidized membrane lipids 
become rigid, lose selective permeability and in worst case lose their integrity 
(Davies, 2000). The membrane potential declines due to increased permeability 
for H+ and other ions affecting ATP-generated and other ion transport 
mechanisms through membranes (Gutteridge, 1995). By altering the membrane 
structure the resistance to thermo-denaturation declines and end-products of 
LPO such as aldehydes are found to cause severe damage to various molecules 
by forming protein adducts with membrane proteins additionally altering their 
structure (Anzai et al., 1999, Lee et al., 2004). The process of lipid peroxidation 
includes three major steps and is outlined in Figure 7.  
LPO is induced by a free radical (R•) and starts with the initiation step ( ) by 
abstracting a hydrogen atom (H+) from the fatty acid chain near a double bond 
leaving a lipid radical (LR•) behind. Under aerobic conditions the propagation (
) continues with the lipid radical (LR•) that combines with oxygen (O2) forming a 
lipid peroxyl radical (LOO•). LOO• reacts with the next unsaturated fatty acid 
chain forming another LR• by abstracting H+ and lipid hydroperoxide (LOOH). 
The LR• serves as a new substrate for the propagation phase and triggers a chain 
reaction creating more LOO• ( ). The termination step ( ) ends the chain 
reaction either by donation of H+ from antioxidants to LOO• forming a non-radical 
and more stable product or with final decomposition of LOOH into end-products 
such as aldehydes (Dobrian et al., 2000). The highly reactive OH• can generate 
LR• and H2O2 out of LOOH. LOO• and LR• can restart the chain reaction of lipid 
peroxidation leading to the accumulation of radicals (Catalá, 2009).  
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Figure 7: Process of lipid peroxidation.  In initiation (1) radicals (R•) attack unsaturated lipids 
(LH) and form a lipid radical (LR•) by abstracting a hydrogen atom (H+). LR• reacts with O2 in 
propagation phase (2) forming lipid peroxyl radical (LOO•) which starts the chain reaction (3) by 
reacting with another LH and forms lipid hydroperoxide (LOOH). Termination (4) includes the 
decomposition of LOOH into aldehydes and donation of H+ to LOO• from antioxidants [adopted 
from (Ayala et al., 2014)]. 
Marker of lipid peroxidation 
Aldehydes such as malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) 
mainly derive in vivo from PUFA with three or more double bonds. They are 
reactive end-products of lipid peroxidation that serve as toxic messengers by 
initiating the formation of free radicals leading to oxidative tissue damage (Catalá, 
2009). The generation of MDA and 4-HNE as oxidative breakdown products of 
lipids in membranes via LOO• and LO• is shown in Figure 8. Both oxidative stress 
markers are widely studied for their role in tissue damage as well as signaling 
molecules in metabolism. In numerous age-dependent diseases increased 
amounts of MDA and 4-HNE were found including Alzheimer’s disease 
(Markesbery and Lovell, 1998, Butterfield et al., 2006) and Parkinson’s disease 
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(Navarro et al., 2009, Castellani et al., 2002), cancer (Gonenc et al., 2001, Cai et 
al., 2012), cardiovascular diseases (Walter et al., 2004), and liver diseases (Dou 
et al., 2012, Sampey et al., 2003). Further investigations are needed concerning 
cellular injury as it is not yet identified whether LPO is the cause for the damage 
or the outcome of earlier cell injury (Grotto et al., 2009). As aldehydes are 
relatively stable and water-soluble they diffuse through the altered oxidized 
membrane reaching targets even outside the membrane distant from their site of 
origin (Davies, 2000). To evaluate the amount of oxidative damage in cells, MDA 
and 4-HNE are determined as stable end-products of the chain reaction of LPO 
initiated by ROS attacks. MDA shows a great reactivity to molecules with free 
amino acid groups and forms partly stable products via cross-links (Janero, 
1990). Further MDA is known to be mutagenic by forming different adducts with 
DNA bases (Esterbauer et al., 1991). These MDA-DNA adducts mainly induce 
base pair substitutions with increased mutation frequencies as seen in normal 
breast tissue of breast cancer patients with higher amounts of MDA-adducts 
compared to breast tissue of women without breast cancer (Wang et al., 1996).  
4-HNE mainly derived from arachidonic and linoleic acid was identified to be even 
in small amounts highly toxic to cells with inhibition of protein and DNA synthesis 
as well as lowering GSH contents in membranes (Benedetti et al., 1980, White 
and Rees, 1984). The reactivity of 4-HNE is based on its reactivity to the amino 
acids cysteine, lysine and histidine forming 4-HNE-protein adducts (Poli et al., 
2008). 4-HNE also affects the DNA as mutagenic agent by binding to guanosine 
bases of DNA forming 4-HNE-DNA adducts (Csala et al., 2015). Additionally, 
binding of 4-HNE to key signal proteins via sulfhydryl groups modulates 
physiological pathways also inducing pathological responses (van der Vliet and 
Bast, 1992). Increased levels of 4-HNE were found in oxidative stress-related 
pathologies such as during reperfusion of rat myocardium (Blasig et al., 1995), in 
plasma of premature infants with chronic lung disease (Ogihara et al., 1999) and 
in patients with alcohol-induced liver injury (Aleynik et al., 1998, Meagher et al., 
1999).  
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Figure 8: Formation of MDA and 4-HNE as end-products of lipid peroxidation. OH• attack 
unsaturated lipid (LH) and initiate the process of lipid peroxidation finally leading to formation of 
LOO• and LO• that further decompose into MDA and 4-HNE. These aldehydes indicate the 
amount of oxidative stress in an organism in form of lipid peroxidation [adopted from (Jomova and 
Valko, 2011)]. 
1.4. Oxidative stress-induced liver damage 
The liver used as a model organ in this study is found to be highly affected by 
increased oxidative stress in form of ROS (Muriel, 2009). Liver tissue contains 
high amounts of PUFA that are priority targets of ROS as well as iron that in its 
free form can catalyze ROS-releasing reactions (Meng and Zhang, 2003). 
Increased age-dependent oxidative stress is linked to hepatic injury as old 
individuals are more likely to suffer from liver diseases with poorer clinical 
outcome due to reduced regeneration capacity (Tajiri and Shimizu, 2013). Figure 
9 outlines the effects of oxidative stress on the liver that finally cause hepatic 
pathologies including fatty degeneration (steatosis), chronic inflammation 
(hepatitis), scar tissue formation (fibrosis) and further destruction of liver structure 
(cirrhosis) as well as hepatocellular carcinoma (HCC) (Li et al., 2015). ROS-
induced pathways harm liver cells via oxidation of DNA that increases the risk for 
HCC and initiation of LPO with accumulation of fatty acids leading to steatosis. 
The ROS-induced formation of protein adducts and mitochondrial dysfunction 
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affect signaling molecules and increase inflammation reactions that lead to 
chronic hepatitis (Cichoz-Lach and Michalak, 2014). Hepatic stellate cells are 
particular sensitive towards ROS attacks and once activated secret collagen to 
form scar tissue that finally remodels liver structure into fibrotic and further 
cirrhotic tissue (Dunning et al., 2013). Oxidative stress-induced liver injury is well 
studied in animal models after the application of carbon tetrachloride (CCl4) or 
ethanol as pro-oxidant agents (Kadiiska et al., 2005, Weber et al., 2003, 
Natarajan et al., 2006). CCl4 has been identified as effective in vivo inducer of 
LPO in membranes causing steatosis in liver tissue (Recknagel et al., 1989). 
Various studies observed that the prior application of antioxidative substances 
including herbal extracts and dietary supplements prevents hepatotoxic effects of 
CCl4 (Lin et al., 2008, Feng et al., 2011, Reyes-Gordillo et al., 2007). 
 
Figure 9: Oxidative stress in the liver causing liver diseases. Exogenous and endogenous 
sources lead to increased oxidative stress in the liver. ROS-induced pathways include oxidation 
of DNA resulting in hepatocellular carcinoma (HCC) and lipid peroxidation with accumulation of 
fatty acids that forms steatosis. Protein adduct formation and mitochondrial dysfunction affect 
signaling molecules and increase inflammation leading to chronic hepatitis. Hepatic stellate cells 
activated by ROS secret scar tissue and remodel liver structure into fibrotic/cirrhotic tissue 
[adopted from (Li et al., 2015)]. 
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The alcohol-induced liver disease (ALD) is one of the leading causes of death 
and disability worldwide and oxidative stress is intensively studied in liver 
pathologies linked to excessive alcohol consumption (Louvet and Mathurin, 
2015). Ethanol is mainly metabolized in the liver by alcohol dehydrogenases but 
also cytochrome P450 oxidases further metabolize toxins and drugs (Wu and 
Cederbaum, 2009). During these reactions in the liver increased ROS are 
generated that could be measured as increased LPO products and oxidative DNA 
damage markers displaying oxidative stress caused by ethanol (Seki et al., 2003, 
Albano et al., 1996). Especially the isoform cytochrome P450 2E1 (CYP2E1) is 
identified to be induced after alcohol ingestion and intragastrical feeding of 
ethanol to rats has been reported to increase CYP2E1 activity and LPO products 
underlining the theory of ROS-induced injury in ALD (French et al., 1993, Rouach 
et al., 1997, Takahashi et al., 1992). Further studies observed that chronic alcohol 
intake weakens the protection against oxidative stress in form of hepatic 
antioxidant defense system mainly measured as reduced antioxidative enzymes 
activities including SOD, CAT and GPx as well as reduced GSH levels (Husain 
et al., 2001, Molina et al., 2003). The prophylactic application of antioxidative 
substances including Gingko bilboa extract (Yao et al., 2006), quercetin (Nussler 
et al., 2010, Liu et al., 2010) and curcumin (Rong et al., 2012) prior to alcohol 
intake is observed to partially reduce ethanol-induced oxidative injury and 
displays a possible approach towards pharmaceutically preventing oxidative 
stress. 
1.5. Heat stress in aging 
During prolonged periods of environmental heat in form of heat waves especially 
people older than 65 years have a higher risk of mortality (Semenza et al., 1996, 
Vandentorren et al., 2006, Vanhems et al., 2003, Conti et al., 2005). Old 
individuals are less tolerant to hyperthermia and more affected by repeated heat 
stress (Semenza et al., 1996). To keep the physiological homeostasis in balance, 
the body has various adaptation mechanisms towards elevated temperatures. 
The production and evaporation of sweat is important to keep the core 
temperature within its range as well as the increase of cutaneous blood flow by 
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distributing the blood from central to peripheral vessels via vasodilatation 
(Kenney et al., 2014). Aging was found to decrease sweat production, prolong 
sweating during long heating times with loss of plasma volume and decrease 
cutaneous blood flow (Dufour and Candas, 2007, Armstrong and Kenney, 1993, 
Kenney et al., 2014). The plasma viscosity increases caused by the loss of fluids 
leading to a higher possibility of coronary blockage with increased risk of 
cardiovascular death (Kenney et al., 2014). To further investigate the relationship 
between the aging process and heat stress, changes that take place in an aged 
organism when confronted to increased temperatures need to be studied. As 
shown by Kenney and Munce in Figure 10, older individuals have a decreased 
sweat gland function with less sweat secretion and a lower cutaneous blood flow 
probably due to altered structure in aged skin compared to their younger 
counterparts in heat stress conditions (Kenney and Munce, 2003). Other studies 
comparing the cardiovascular system under passive heating investigated a 
reduced increase in cardiac output and less redistribution from visceral circulation 
(Minson et al., 1998). Former studies in gold miners suffering from severe heat 
stroke have also shown that the liver is highly affected from heat stress in form of 
liver injury (Kew et al., 1970, Kew et al., 1971). 
 
Figure 10: Age-related changes in heat stress conditions.  Older people sweat less, have a 
reduced cutaneous blood flow, a smaller increase in cardiac output and the blood redistribution 
from renal and splanchnic circulations is reduced [adopted from (Kenney and Munce, 2003)]. 
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By focusing on the molecular level, elevated temperatures as a form of external 
stress stimulate the ROS production and further increase the oxidative stress in 
an organism (Flanagan et al., 1998). Studies have shown that the respiratory 
chain of mitochondria gets uncoupled (i.e. loss of repspiratory control) when the 
temperature rises above a certain level and increased amounts of O2-• and H2O2 
accumulate (Salo et al., 1991). Near-by structures inside the mitochondria are 
attacked and H2O2 additionally affects distant structures as it diffuses easily 
through cell membranes (Slimen et al., 2014). Different mechanisms have been 
identified as protection of the cell in heat stress. In hyperthermia the organsim 
produces so-called heat shock proteins (HSP) to repair denaturated proteins 
(Ristow and Schmeisser, 2014). The HSP synthesis and their function as 
chaperones for proteins is shown in Figure 11 (Slimen et al., 2014). Under the 
influence of physiological stressors like hyperthermia and oxidative stress protein 
degeneration occurs inside cells. Heat stress transcription factors (HSF) are 
activated and induce the production of mRNA encoding for HSP and finally lead 
to HSP synthesis. HSP serve as so-called molecular chaperones and facilitates 
the correct folding of degraded proteins. Different HSP have been identified and 
they are divided into groups according to their molecular masses. Especially the 
70 kDa HSP family (HSP70 and HSP72) was found to be strongly induced in heat 
shock conditions (Kiang and Tsokos, 1998, Li and Srivastava, 2001). HSP70 
supervises during heat stress the correct folding of intracellular proteins and 
detects misfolded or denatured proteins (Yamamoto et al., 2000). They form a 
complex with these proteins and either support the transformation into the correct 
form or assist with their removal (Hightower, 1991). The cell is protected from 
stress injury and the ability to recover from higher levels of stress is enhanced by 
HSP (Blake et al., 1991). Various studies on heat shock protein formation after 
heat stress in aging organism showed reduced HSP formation in old individuals 
that might be caused by a weakened response to stress signals (Kregel and 
Moseley, 1996, López-Otín et al., 2013). 
22 
 
 
Figure 11: Schematic diagram of HSP synthesis. Physiological stressors (e.g. heat stress) 
induce the accumulation of denatured proteins and activate heat stress transcription factors 
(HSF). They are further processed in the nucleus and lead to transcription of HSP mRNA. HSP 
are synthesized and convert the denatured protein into is original formation [adopted from (Slimen 
et al., 2014)]. 
In heat stress conditions upregulated levels of protection mechanisms including 
GSH redox metabolism with increasing GSH production to buffer ROS are 
measured (Flanagan et al., 1998). Low intracellular GSH levels were identified to 
weaken the resistance of cells against hyperthermia (Flanagan et al., 1998) and 
increased levels of oxidized GSH as GSSG in the liver were found after ischemia 
indicating increased scavenging reactions of GSH (Abdalla et al., 1990). 
1.6. BMBF joint research project OXISYS  
This thesis is part of the subproject OXISYS that is integrated in the joint research 
project GerontoSYS II of the Federal Ministry of Education and Research (BMBF) 
under the title “Role of oxidative injury in aging and therapeutic implications” 
consisting of 6 partners. OXISYS research groups analyze aging processes 
through oxidative stress in the liver as model organ whereas other projects of 
GerontoSYS II examine various cells including brain tissue, fibroblasts of skin 
tissue and stem cells (BMBF, 2016). The aim of OXISYS subproject is to identify 
and further analyze potential biomarkers for clinical diagnosis involved in ROS-
induced hepatic aging and to discover and evaluate their possible target 
structures in cell metabolism. The importance of these targets might further be 
proved by application of certain target-directed substances that interact and 
protect highly affected structures in the human liver during cellular aging. 
Therefore, the project is not only important for basic research of cell aging and 
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organ regeneration but also relevant for clinical usage. The understanding of key 
factors and metabolic pathways is necessary to improve diagnostic and 
therapeutic interventions resulting in higher quality of life allowing better 
prediction and prevention of aging processes. The experimental study of ROS-
induced hepatic aging processes in rats and humans including in vivo and in vitro 
experiments in line with OXISYS subproject are performed by Charité Berlin, 
Pharmacelsus GmbH Saarbrücken, Eberhard Karls University 
Tübingen/Siegfried Weller Institut and University of Saarland. To mathematically 
analyze the generated data in the experiments and to establish in silico models 
that further allow simulation of aging processes and potential influencing factors 
two industrial partners, Hans-Knöll-Institut e.V. Jena and Insilico Biotechnology 
AG Stuttgart, are included as well.  
 
Figure 12: Structure of joint research project OXISYS [modified from (Kraft, 2012)]. 
1.7. Aim of the project  
As part of the in vivo experimental setup of the OXISYS subproject, the aim of 
this thesis is to analyze the influence of oxidative stress in form of hyperthermia 
(up to 41°C) on differently aged male Wistar rats by measuring markers for lipid 
peroxidation (MDA, 4-HNE) and cell damage (LDH, ALT) in serum and liver tissue 
before and after two heat stress episodes. The hypothesis is an age-related 
increase of liver damage in old rats caused by oxidative stress after heat stress. 
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Untreated control groups divided into young, middle-aged and old rats were 
included to display the basal level of markers. The heat-stressed group consists 
of middle-aged and old rats that were liquidated at four points in time after the 
heating (0 h, 2 h, 6 h, 24 h). The liver was chosen as model organ as it has various 
diverse functions in the body and was identified to be affected by ROS-induced 
tissue damage from environmental stressors such as heat stress. Further H&E-
stained liver sections before and after heat stress were histologically analyzed to 
visualize age-dependent hepatocellular damage. Focus lays on adaptation as 
well as protection mechanisms against tissue injury from higher stress levels after 
hyperthermia. The animal model is an important step towards the identification of 
biomarkers in vivo as diagnostic tools for detecting liver aging processes that later 
might be therapeutically used in humans to display and prevent the aging of an 
organism. 
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2. Materials and Methods 
2.1. Materials 
2.1.1. Chemicals 
Table 1: List of used solutions, solids and buffers. 
1,1,3,3-Tetraehtoxypropane (TEP) Sigma-Aldrich Chemie GmbH   
2-Thiobarbituric acid (TBA) Sigma-Aldrich Chemie GmbH   
4-HNE ELISA Kit Cusabio Biotech Co. Ltd. 
Acetic Acid  Carl Roth GmbH + Co. KG 
Bovine Serum Albumin (BSA) Carl Roth GmbH + Co. KG 
CuSO4 stock solution (Cfinal 1%) 1 g CuSO4*5 H2O  
100 ml ddH2O 
Copper(II) sulfate pentahydrate  
(CuSO4*5 H2O) 
Carl Roth GmbH + Co. KG 
Deoxycholic acid sodium salt (DOC) Carl Roth GmbH + Co. KG 
Ethylenediamine tetraacetic acid  
disodium salt (EDTA) 
Carl Roth GmbH + Co. KG 
Fluitest GPT/ALT Kit   
Order No. 1186 
Analyticon Biotechnologies AG 
Fluitest LDH-L  
Order No. 2222 
Analyticon Biotechnologies AG  
Folin & Ciocalteu’s phenol Sigma-Aldrich Chemie GmbH   
Na-K-Tartrate stock solution (Cfinal 2%) 2 g Na-K-Tartrate  
100 ml ddH2O 
Na-K-Tartrate Sigma-Aldrich Chemie GmbH   
Na2CO3 stock solution (Cfinal 2%) 20 g Na2CO3  
950 ml ddH2O 
50 ml 2 M NaOH 
n-Butanol  Sigma-Aldrich Chemie GmbH   
Pyridine  Carl Roth GmbH + Co. KG 
RIPA stock solution 0.121 g TRIS Base  
0.58 g NaCl 
500 µl Tergitol solution 
0.3 g DOC  
0.372 g EDTA  
Sodium carbonate (Na2CO3) Carl Roth GmbH + Co. KG 
Sodium chloride (NaCl) VWR International GmbH 
Sodium hydroxide (NaOH) Carl Roth GmbH + Co. KG 
Tergitol solution  Sigma-Aldrich Chemie GmbH   
TRIS Base  Sigma-Aldrich Chemie GmbH   
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2.1.2. Equipment 
Table 2: List of used equipment. 
AF80 Ice flaker Scotsman Ice Systems 
Aqualine AL 25 Lauda Dr. R. Wobser GmbH 
& Co. KG 
Cellstar 96 Well Microplate Greiner Bio-One 
International GmbH 
Cellstar Tube 15 ml Greiner Bio-One 
International GmbH 
Cellstar Tube 50 ml Greiner Bio-One 
International GmbH 
Costar Stripettes 5 ml  Corning Incorporated 
Costar Stripettes 10 ml Corning Incorporated 
Costar Stripettes 25 ml  Corning Incorporated 
Costar Stripettes 50 ml  Corning Incorporated 
Digital Disruptor Genie Scientific Industries, Inc. 
Disposable Scalpel Feather Safety Razor Co., 
Ltd. 
FLUOstar Omega Microplate Reader BMG Labtech GmbH 
Fridge +4°C   Liebherr-International 
Deutschland GmbH 
Fridge -20°C  Liebherr-International 
Deutschland GmbH 
Fridge -80°C Thermo Fisher Scientific Inc. 
Heraeus Fresco 17 Centrifuge Thermo Fisher Scientific Inc. 
Heratherm Oven Thermo Fisher Scientific Inc. 
Incubator Binder GmbH 
Lambda Multichannel Pipettor 5 - 50 µl Corning Incorporated 
Lambda Multichannel Pipettor 20 - 200 µl Corning Incorporated 
Lambda Multichannel Pipettor 50 - 300 µl  Corning Incorporated 
Lambda Single-channel Pipettor 2 - 20 µl Corning Incorporated 
Lambda Single-channel Pipettor 10 - 100 µl Corning Incorporated 
Lambda Single-channel Pipettor 20 - 200 µl Corning Incorporated 
Lambda Single-channel Pipettor 100 - 1000 µl Corning Incorporated 
LSE Vortex Mixer Corning Incorporated 
Megafuge 40 R Thermo Fisher Scientific Inc. 
Microscope Primo Vert Carl Zeiss AG 
Pipette Tips 0.1 - 10 µl Colorless Sorenson BioScience, Inc. 
Pipette Tips 2 - 200 µl Yellow Sarstedt AG & Co. 
Pipette Tips 100 - 1000 µl Blue Ratiolab GmbH 
Precellys Ceramic Kit 1.4/2.8 mm Peqlab GmbH 
Rotilabo-microcentrifuge tubes 1.5 ml Carl Roth GmbH + Co. KG 
Sky Line Digital Orbital Shaker  ELMI Ltd.  
Spatula Set Carl Roth GmbH + Co. KG 
Sterile Bench Safe 2020 Thermo Fisher Scientific Inc. 
Thermo-Shaker TS-100 Biosan 
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Weight ABJ 120-4M KERN & SOHN GmbH 
Weight PCB 250-3 KERN & SOHN GmbH 
2.1.3. Animals 
72 male Wistar rats (RjHan: WI) of three different age groups were obtained from 
Janvier Labs (Genest-St-Isle, France). They were housed in a temperature-
controlled room (20-24°C) and adapted to a 12 h light/ 12 h dark cycle. The 
animals were given free access to food (ssniff ® R/M-H, 10 mm) and water before 
and during the study. Experiments were started after an acclimatization period of 
at least 1 week. All experimental procedures employed were approved by and 
conducted in accordance with the regulations of the local Animal Welfare 
authorities (Landesamt für Gesundheit und Verbraucherschutz, Abteilung 
Lebensmittel- und Veterinärwesen, Saarbrücken, file number C1 2.4.2.2. Nr. 
12/2012). The heat stress experiments as well as the sampling of serum and 
tissue samples were performed by Pharmacelsus GmbH (Saarbrücken, 
Germany). The rats were divided into two groups: 28 young, middle-aged and old 
rats in the untreated control group as shown in Figure 13 and 44 middle-aged 
and old rats in the heat-stressed group that were liquidated at four points in time 
after heat stress as presented in Figure 14. Untreated young rats are 7 weeks 
old, middle-aged rats are 6 to 7 months old and old rats 23 months. The average 
body weight constantly increases from young to middle-aged rats with highest 
weight in old rats. Heat-stressed middle-aged rats are 7 months old and old rats 
aged 23 months. The average body weight in old heat-stressed rats is higher in 
every time group compared to middle-aged heat-stressed rats.  
 
Figure 13: Overview of untreated control group. Young (7 weeks), middle-aged (6/7 months) 
and old (23 months) rats are included in the untreated control group. This figure shows the 
average body weight and number of individuals per age group. 
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2.1.4. Heat stress experiments 
Middle-aged and old male Wistar rats were heat-stressed according to a modified 
protocol of the described heat stress experiment of Zhang et al. (Zhang et al., 
2003). To record and supervise the exact body temperature during the heat 
stress, a temperature transponder (IPTT-300, Plexx B.V., The Netherlands) was 
implanted subcutaneously in the neck region under a short anaesthesia using 
isoflurane. To determine baseline data, a serum sample (300 µl) was 
simultaneously taken from the tail artery. After 3-5 days of implanting the 
transponder, the heat stress sessions were performed. Therefore, two rats with 
nearly the same weight at a time were put into a warming cabinet (small animal 
recovery chamber, Harvard Apparatus GmbH, Germany) provided with bedding, 
but no food or water. To minimize other stress factors, the animals were 
familiarised one day before the actual heat stress sessions to the warming 
cabinet without any heating by keeping them in the experimental environment for 
one hour. Each rat of the heat-stressed group was exposed to two periods of 
identical heat stress in the morning of two consecutive days. During the heat 
stress, their body temperature was registered every 5 minutes via the 
subcutaneous temperature transponder. The animals were heated in the 
warming cabinet for exactly 60 minutes to achieve a body temperature above 
40°C (target heating rate: 0.06°C/min), followed by exactly 30 minutes keeping 
the body temperature between 40 and 42°C. After the second heat stress on day 
2, each rat was eliminated using an overdose of isoflurane anaesthesia after a 
certain defined point in time (0 h (i.e. directly after heat stress), 2 h, 6 h, 24 h) and 
blood was drawn by cardiac puncture for preparation of serum. At the end, livers 
were dissected for preparation of tissue samples. All serum and liver tissue 
samples were stored in a freezer at -80°C and aliquoted to prevent repeated 
freeze-thaw cycles, which would affect measured enzyme activities due to altered 
protein conformation. 
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Figure 14: Overview of middle-aged and old rats after heat stress. 44 middle-aged (7 months) 
and old (23 months) male Wistar rats are included in the heat stress experiment, subdivided into 
four groups after heat stress according to time of liquidation (0 h, 2 h, 6 h, 24 h). This figure shows 
the average body weight and number of individuals per age group at four points in time. 
2.2. Methods 
2.2.1. Human serum for preliminary experiments 
The serum of young people (Ø age: 27 years) and the serum of old patients (Ø 
age: 72 years) was used for preliminary experiments trying to proof the 
experimental setup. The young control group (N = 8, 4 men and 4 women) were 
healthy non-smokers whereas all in the group of older patients (N = 8, 4 men and 
4 women) were suffering from liver diseases such as hepatocellular carcinoma, 
liver metastasis of colorectal carcinoma and cholangiocarcinoma.  
2.2.2. Isolation of cytosol from liver tissue  
The homogenization of liver tissue was performed using a disruptor, pre-cooled 
tubes with ceramic beads and always chilling the tubes on ice immediately to 
avoid loss of enzymatic activity. The liver tissue samples stored at -80°C were 
thawed on ice. After thawing a piece of liver tissue (about 50 mg) was chopped 
using a scalpel. The exact weight was noted and the tissue was further cut into 
little pieces with the scalpel and then transferred to pre-cooled tubes filled with 
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ceramic-beads (Precellys Ceramic Kit Ø 1.4 and 2.8 mm, Peqlab). 300 µl of RIPA 
stock solution was added per tube and spinned down shortly in the 
microcentrifuge at 4°C. Afterwards the tissue samples were homogenized in a 
disrupter at 2850 rpm for 1 minute and immediately chilled on ice for another 3 
minutes. This disruption cycles with cooling time were repeated three times for 
each sample until the solution appeared homogeneous. The homogeneous 
lysates were transferred to new 1.5 mL Eppendorf tubes and then centrifuged for 
30 minutes (800 g, 4°C) to separate cell nuclei and other cell particles. The 
supernatant containing cytosol was frozen immediately by using liquid nitrogen 
and stored in the freezer at -80°C.  
2.2.3. Lowry protein assay 
Every cell in an organism contains various proteins, including enzymes. The 
determination of total protein levels in a sample is necessary to compare 
measured protein amounts in liver tissue. Lowry protein assay was used in a 
modified method based on Lowry et al. 1951 and generally consists of two steps 
outlined in Figure 15. Step 1 is the Biuret reaction including the reaction of copper 
ions (Cu2+) with peptide bonds of proteins in an alkaline solution by reducing Cu2+ 
into Cu+ forming a purple colored complex (Waterborg, 2009). The Folin & 
Ciocalteau’s reaction in step 2 contains phosphomolybdate and 
phosphotungstate that reduce the copper-protein complex, enhance the color 
and turn it into blue (Lowry et al., 1951, Smith et al., 1985). 
 
Figure 15: Lowry protein assay reactions step by step. Cu2+ ions react with peptide bonds of 
proteins forming a complex that is further processed with Folin & Ciocalteau’s reagent creating a 
blue colored product [adopted from (Johnson, 2012)]. 
The Standard operating procedure of the lab served as guideline. Briefly, the 
protein content was measured photometrically as intensity of blue color.       
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Bovine Serum Albumin (BSA) was used in the following concentrations to 
generate the standard curve. 
Table 3: BSA standard curve mass concentrations. 
BSA standard [µg/µl] 
10 8 6 4 2 1 0 
Solution A (20 µl Na-K-Tartrate stock solution, 20 µl CuSO4 stock Solution, 1960 
µl Na2CO3 stock solution) and B (500 µl Folin & Ciocalteu’s phenol, 1000 µl 
ddH2O) were prepared freshly each time before measurement. 2 µl of each BSA 
standard concentration as well as 2 µl of each sample were pipetted into a 96-
well-plate in triplicates. 150 µl of Solution A was added per well and incubated 
shaking for 10 minutes at room temperature. Then 30 µl of Solution B is added 
per well and again incubated shaking at room temperature for 2 h. The adsorption 
was measured at 750 nm using a microplate reader. The measured optical 
density of the samples was calculated from the generated standard curve. As 
samples were diluted (1:3) and cytosol of liver tissue (1:6) the results of the 
calculation were multiplied by the dilution factor.  
2.2.4. Lactate dehydrogenase activity assay 
The lactate dehydrogenase enzyme (LDH) is a cytosolic enzyme present in 
various body fluids and tissues, mainly in the heart, liver, muscles and kidneys 
(Kopperschlager and Kirchberger, 1996). LDH is a tetramer composed of two 
types of subunits (heart: H or muscle: M) that can be randomly matched forming 
five isoenzymes (Bais and Philcox, 1994b). LDH catalyzes in anaerobic 
conditions the reversible reaction of lactate to pyruvate by using the reduction of 
NAD+ into NADH as electron transfer. 
 
Figure 16: Principle of LDH activity assay. [adopted from (Bais and Philcox, 1994a)]. 
The formation of NADH is proportional to the LDH activity and can be 
photometrical measured. As LDH is located in the cytosol of cells, high LDH 
serum levels indicate leakage through the cell membrane after certain cell 
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damage. An increased LDH activity is not specific for liver injury and other 
markers for liver damage should be measured additionally to identify other 
sources for increased LDH in serum. High levels of increased serum LDH could 
be measured in megaloblastic anemia and disseminated carcinoma 
(Kopperschlager and Kirchberger, 1996). The increase of NADH is directly 
proportional to LDH activity and can be detected photometrically at 340 nm. To 
quantify LDH activity in serum and liver tissue a commercial test kit was used 
following manufacturers’ instructions (Fluitest LDH-L Kit, Analyticon 
Biotechnologies AG). According to the user manual five parts of reagent 1 (2-
Aminomethylpropanol pH 9.4 and Lithium lactate) and one part of reagent 2 
(Imidazole and NAD+) were mixed freshly each time before usage. First 5 µl of 
sample was pipetted onto a 96-well-plate in duplicates followed by 180 µl of 
working solution (5 R1 + 1 R2) per well. After an incubation time of 90 seconds 
the absorbance was measured at a wavelength of 340 nm once every minute 
over 10 minutes using a microplate reader. The liver tissue samples were diluted 
(1:100) preventing too high concentration that interferes with photometric 
measurements and the results were multiplied by the dilution factor. The LDH 
activity was calculated by using the following formula: 
 
Figure 17: Formula for calculation of LDH activity.  A is activity, ∆ɛ is molecular extinction 
coefficient, Vtotal is total volume per well, Vsample is sample per well and d is liquid layer thickness.  
2.2.5. Alanine-aminotransferase activity assay  
The alanine-aminotransferase enzyme (ALT) (formerly named glutamate-
pyruvate-transaminase, GPT) is known as liver specific enzyme mainly located 
in hepatocytes but also minor amounts in kidneys and heart tissue (Dufour et al., 
2000). As ALT activity is about 3000 times higher in cytoplasm of hepatocytes 
compared to serum, increased serum levels of ALT are diagnostically used to 
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detect liver parenchymal damage (Kim et al., 2008). ALT belongs to 
aminotransaminases and transfers the amino group of L-alanine to 2-
oxoglutarate revealing L-glutamate and pyruvate as described in Figure 18 
(Senior, 2012). Pyruvate formed in reaction (I) is immediately further processed 
in the indicator reaction (II) and ALT activity is measured via the rate of oxidation 
of NADH by LDH (Bergmeyer et al., 1986). The decrease of NADH is directly 
proportional to ALT activity and is measured photometrically at a wavelength of 
340 nm.  
 
Figure 18: Principle of ALT activity assay. Two coupled reactions lead to decreased levels of 
NADH proportional to ALT activity in the sample that are measured photometrically at 340 nm. 
For quantification of ALT activity in serum a commercial test kit was used 
following manufacturers’ instructions (Fluitest GPT/ALT Kit, Analyticon 
Biotechnologies AG). According to the user manual five parts of reagent 1 (Tris 
buffer pH 7.8, L-alanine and LDH) and one part of reagent 2 (NADH2 and 2-
oxoglutarate ) were mixed each time freshly before usage. First 20 µl of sample 
was added onto a 96-well-plate followed by 165 µl of working solution (5 R1 + 1 
R2) per well. After an incubation time of 60 seconds the absorbance was 
measured at a wavelength of 340 nm once every minute over 10 minutes using 
a microplate reader. The ALT activity was calculated by using the following 
formula: 
 
Figure 19: Formula for calculation of ALT activity. A is activity, ∆ɛ is molecular extinction 
coefficient, Vtotal is total volume per well, Vsample is sample per well and d is liquid layer thickness.  
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2.2.6. Malondialdehyde assay 
To determine the degree of oxidative stress, MDA is measured as marker for 
increased lipid peroxidation. MDA is a decomposition product mainly of 
arachidonic acid that is generated via lipid peroxidation processes and can be 
mutagenic by reacting with DNA forming MDA-DNA adducts (Lykkesfeldt, 2007, 
Marnett, 1999). The MDA Assay used in this setting is based on the thiobarbituric 
acid (TBA)-Method outlined in Figure 20 according to Ohkawa et al. with 
modifications (Ohkawa et al., 1979). Two molecules of TBA react under heating 
and acidic conditions with one molecule of MDA to molecule-bound MDA forming 
a fluorescent red product that could be photometrically measured (Spiteller, 
2001).  
 
Figure 20: Principle of TBA-method for determination of MDA level in serum and liver 
tissue. One molecule of MDA reacts with two molecules of TBA forming a fluorescent red product 
[modified from (Yahyavi et al., 2016)]. 
The TBA-Method for determination of MDA level in serum was performed in 
triplicates and distilled water was used as blank value. The breakdown product 
of Tetraehtoxypropane (TEP) via acid hydrolysis as form of pure MDA was used 
to generate the standard curve (Seljeskog et al., 2006). First 45 µl of serum 
sample and 45 µl of TEP solution with highest concentration of 25 µM were 
transferred to separate Eppendorf tubes. Then 5 parts of 0.6% TBA (0.12 g TBA 
in 20 ml ddH2O) and 4 parts of 25% acetic acid (10 ml acetic acid in 30 ml ddH2O) 
were mixed. 135 µl of TBA-acetic acid mixture (5:4) was added to each sample 
and standard. The samples and standard were heated at 100°C shaking at 250 
rpm for 1 h. After heating all tubes were immediately kept on ice to stop the 
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reaction. After that, 125 µl of n-Butanol mixed with pyridine in a 15:1 ratio was 
added per sample and 250 µl of this solution per standard. From now on the tubes 
needed protection from daylight and were covered with aluminum foil. After 10 
minutes of incubation on ice the tubes were vortexed thoroughly for 15 seconds 
per tube and then centrifuged for 5 minutes (7000 g, 4°C). Now the upper phase 
which appears red and contains organic material is loaded with a quantity of 50 
µl per sample and 100 µl per standard on the plate. The TEP standard (25 µM) 
is diluted with n-Butanol via a two-fold dilution series as described in Table 4 to 
generate the standard curve.  
Table 4: Standard curve for TBA-Method generated as two-fold dilution series. 
Standard TEP solution  Applied chemicals 
25 µM 100 µl of standard 
12.5 µM 50 µl n-Butanol + 50 µl of 25 µM standard 
6.25 µM 50 µl n-Butanol + 50 µl of 12.5 µM standard 
3.13 µM Continue as above 
1.56 µM Continue as above 
0.78 µM Continue as above 
0.39 µM Continue as above 
0 µM 50 µl n-Butanol 
 
The fluorescence was measured at excitation wavelength of 544 nm and 
emission wavelength of 590 nm using a microplate reader. For the analysis of 
results the software GraphPad Prism 6.0 was used to plot the fluorescence 
intensities of each standard concentration against the corresponding 
concentrations and perform linear regression to determine the sample 
concentrations by using the resulting linear equation. For each MDA assay a 
standard curve was created to validate that sample concentrations of MDA are in 
the linear range of the standard curve (Zhang et al., 2003).  
For determination of MDA in liver tissue samples the isolation of cytosol from liver 
tissue was necessary as described above. Instead of distilled water RIPA stock 
solution was used as blank value. First 30 µl of supernatant and 30 µl of TEP 
solution (25 µM) were transferred to separate Eppendorf tubes. Then 150 µl of 
TBA-acetic acid mixture (5:4) was added to each sample and standard. The 
following steps were identical to determination of MDA in serum.  
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2.2.7. 4-Hydroxynonenal ELISA  
Derived as relatively stable end-product of lipid peroxidation from PUFA in 
membranes, 4-HNE is a well-studied marker for oxidative stress (Uchida et al., 
1999). For quantification of 4-HNE concentrations in this setting, the 4-HNE 
Sandwich enzyme-linked immunosorbent assay (ELISA) was carried out using a 
commercial 4-HNE ELISA kit (Cusabio Biotech Co. Ltd, China). The assay was 
performed following the instructions in the manufacturers’ manual. The principle 
of 4-HNE ELISA is outlined in Figure 21. An antibody specific for 4-HNE has been 
pre-coated onto a microplate. Any 4-HNE present in the sample or standard is 
bound to the immobilized antibody. After removing any unbound substances, a 
biotin-conjugated antibody specific for detection of 4-HNE is added to the wells. 
After washing, avidin-conjugated Horseradish Peroxidase (HRP) is added to the 
wells. Following another wash to remove any unbound avidin-enzyme reagent, a 
substrate solution is added to the wells and color develops in proportion to the 
amount of 4-HNE bound in the initial step. The color development is stopped 
using stop solution and the intensity of the color is measured.  
 
Figure 21: Principle of 4-HNE Sandwich ELISA method. Pre-coated antibodies specific for 4-
HNE react with 4-HNE in sample and bound 4-HNE is detected via detection antibody conjugated 
with HPR that forms a coloured product with substrate solution [modified from (Technology, 
2016)]. 
First Biotin-Antibody, HRP-avidin and wash buffer were prepared freshly before 
each usage. The standard curve was created with stock solution (40 ng/ml) and 
sample diluent provided in the kit. Therefore, 250 µl of sample diluent were 
pipetted into each tube S0-S6 and a two-fold dilution series was produced with 
stock solution as described in Table 5. The sample diluent serves as a blank 
value (S0). 
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Table 5: Standard curve for 4-HNE ELISA generated as two-fold dilution series. 
Tube S7 S6 S5 S4 S3 S2 S1 S0 
ng/ml 40 20 10 5 2.5 1.25 0.625 0 
First 100 µl standard and cytosol of liver tissue were added to each well that is 
pre-coated with HNE specific antibody. After covering with an adhesive strip 
incubation for 2 h at 37°C followed. Afterwards the liquid of each well was 
removed without washing. 100 µl of the Biotin-antibody is added to each well, 
covered again with a new adhesive strip and incubated for 1 h at 37°C. Then 
each well was aspirated and washed three times in total applying 200 µl of the 
enclosed wash buffer per wash leaving buffer in wells for 2 minutes of soaking 
time. After the last wash, the liquid was removed completely by inverting the plate 
and blotting it against clean paper towel. For the next step 100 µl of HRP-avidin 
is added to each well, again covered with an adhesive strip and incubated for 1 
h at 37°C. The aspiration-washing process was repeated for five times in total as 
described above. Then 90 µl of TMB substrate is added per well and from now 
on the plate was protected from light by a wrapping of aluminum foil followed by 
incubation for 25 minutes at 37°C. Afterwards the reaction is stopped by pipetting 
50 µl of stop solution into each well and the color appeared blue. To determine 
the optical density, the absorbance is measured at a wavelength of 450 nm using 
a microplate reader. The readings at 540 nm were subtracted from the readings 
at 450 nm to correct optical imperfections in the plate. GraphPad Prism version 
6.0 was used to create a dose-response curve and concentration of 4-HNE in 
samples was calculated from the generated standard curve. The tissue samples 
were diluted (1:2000) preventing too high concentration that interferes with 
photometric measurements and the results of the calculation were multiplied by 
the dilution factor. 
2.2.8. H&E-staining of liver sections 
The Hematoxylin & Eosin-staining (H&E-staining) of liver sections was performed 
to visualize possible damage in liver tissue of untreated and heat-stressed rats 
comparing different ages and points in time after heat stress (0 h, 2 h, 6 h, 24 h). 
Basic hematoxylin stains the basophile DNA blue/violet and the acidophil 
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cytoplasm is stained red by eosin (Fischer et al., 2008). After cutting paraffin 
slices from liver tissue, the slides were stained according to the protocol of the 
Department of Pathology from University of Tuebingen in an automatic staining 
machine (Feldman and Wolfe, 2014). Histological images of liver sections were 
made using Microscope Primo Vert (Carl Zeiss AG). Focus was on examination 
of hepatic lobules with central vein for various signs of hepatocellular damage 
such as fatty degeneration, hepatocellular vacuolization, ballooning degeneration 
and apoptosis (Grizzi et al., 2013). For quantitative analysis, three liver sections 
were used per age group and at each point in time after heat stress.  
2.2.9. Statistical analysis  
All Data were expressed as mean ± standard deviation (SD). All calculations and 
graphics were created using the statistic software GraphPad Prism 6.0 (San 
Diego, CA, USA). Means of age groups within heat-stressed and control animals 
were compared by one-way analysis of variance (ANOVA). Differences between 
young and old human serum were calculated by Mann-Whitney U t-test. 
Statistical outliers were determined with ROUT outlier test and excluded from 
calculations. Differences were considered statistically significant at values of 
p<0.05. 
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3. Results 
By measuring markers for cell damage and oxidative stress, this thesis analyzes 
age-related differences in stress response after in vivo heat stress. Young (7 
weeks), middle-aged (6/7 months) and old (23 months) rats are included as 
control group. Middle-aged (7 months) and old (23 months) rats were exposed to 
two-phase heat stress and liquidated at four points in time after the second heat 
stress (0 h, 2 h, 6 h, 24 h). For preliminary experiments and to proof 
measurements human serum of young (Ø 27 years) and old (Ø 72 years) 
individuals is included. General cell damage is measured using LDH activity and 
ALT activities display specifically possible hepatic injury. Further H&E-staining of 
liver sections are examined to visualize hepatocellular damage. Lipid 
peroxidation markers MDA and 4-HNE are determined as indicators for increased 
oxidative stress.  
3.1. Human serum for preliminary experiments 
The serum of young individuals (Ø 27 years) obtained from healthy non-smokers 
and the serum of old patients (Ø 72 years) with liver diseases were compared in 
their amount of LDH and ALT activity as well as MDA (Figure 22). LDH activity 
increases significantly in old patients indicating higher general cell damage. The 
LDH activity is nearly two times higher in older patients compared to the young 
group. ALT as an indicator of hepatic damage is measured in both groups. The 
mean value of old individuals is slightly higher compared to young but there is 
high variation in the old group indicating fluctuations that could be caused by 
different liver diseases. The serum of the young group is directly processed after 
blood withdrawal, whereas the serum of older patients is taken during liver 
surgery and processed after a transport period. Due to the transport period of the 
serum of old patients the enzyme activities could be affected and measured 
activities might not display the actual in vivo situation. Results of MDA assay 
indicates slightly higher MDA levels for old individuals compared to their younger 
counterparts. Prior to the experiments a significant increase of markers for 
cellular damage (LDH), especially liver damage (ALT) and increased levels of 
oxidative stress marker MDA in older patients were suggested. 
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Figure 22: LDH, ALT and c(MDA) in human serum of young and old individuals. Serum 
levels of LDH significantly increase in old patients whereas ALT activity and MDA levels show 
mild elevated amounts in old. ***p<0.01 (young versus old group). 
Table 6: Serum levels of LDH, ALT and MDA in serum of young and old patients. Values are 
presented as mean ± SD. ns (not significant). 
 Young patients (N = 8) Old patients (N = 8) 
Protein content [mg/ml] 84.89 ± 13.05  71.11 ± 7.16 (ns) 
LDH activity [U/L] 36.82 ± 14.38  67.74 ± 13.54 (***p<0.01) 
ALT activity [U/L] 13.72 ± 9.50 26.47 ± 19.17 (ns) 
MDA Assay [nmol/ml] 4.02 ± 1.04 5.20 ± 1.41 (ns) 
 
3.2. H&E-staining of liver sections 
Images for the histological evaluation of Hematoxylin & Eosin-stained liver 
sections of untreated rats are shown in Figure 23. The liver morphology appears 
homogenous in young rats (A+B) with normal configurated nuclei. In liver sections 
of old rats (E+F) forms of severe liver injury including hepatocellular 
vacuolization, lipid-filled hepatocytes and sinusoidal congestion are observed 
that indicate increased liver damage in aged individuals. In comparison to old rats 
show middle-aged rats minor liver injury with signs of apoptosis and few fatty 
infiltrates (C+D). The liver sections of different aged untreated rats show a slight 
increase of liver damage during aging.  
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Figure 23: H&E-stained liver sections of young, middle-aged and old untreated rats. Liver 
morphology was normal in young rats (A+B) and more severe liver injury was found in old rats 
(E+F, arrows) including fatty degeneration and hepatocellular vacuolization. Middle-aged rats 
(C+D) show only slight liver damage. Scale bars A, C, E: 200 µm and B, D, F: 100 µm.  
Images for the histological evaluation of H&E-stained liver sections of middle-
aged and old rats after heat stress are shown in Figure 24.The middle-aged rats 
(MA) show few signs of liver damage at all points in time (A: 0 h, C: 2 h, E: 6 h, 
G: 24 h). More severe liver damage appears in old rats (O) compared to MA at 
all points in time including fatty infiltration, sinusoidal congestion, hepatocellular 
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vacuolization and ballooning degeneration (B: 0 h, D: 2 h, F: 6 h, H: 24 h, arrows). 
By comparing old rats at different points in time after heat stress no significant 
increased damage is found. There is a higher grade of liver damage with 
increased rate of necrosis, fatty infiltration and ballooning degeneration in old rats 
after heat stress compared to untreated control group. 
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Figure 24: H&E-stained liver sections of middle-aged and old rats at different points in time 
(0 h, 2 h, 6 h, 24 h) after heat stress. Middle-aged rats (MA) show few signs of liver damage at 
all points in time (A: 0 h, C: 2 h, E: 6 h, G: 24 h). More severe liver damage appears in old rats 
(O) compared to MA at all points in time including fatty infiltration, sinusoidal congestion, 
hepatocellular vacuolization and ballooning degeneration (B: 0 h, D: 2 h, F: 6 h, H: 24 h, arrows). 
Scale bars: 200 µm. 
3.3. Serum and liver tissue of untreated rats  
3.3.1. Protein content  
The results of the Lowry protein assay in serum and liver tissue of young, middle-
aged and old untreated rats are shown in Figure 25. The protein content in serum 
and liver tissue comparing the different age groups is nearly equal with slightly 
increased mean liver tissue protein levels. The protein mass concentrations are 
used to normalize measured enzyme activities of LDH and ALT as well as levels 
of MDA and 4-HNE in liver tissue. 
 
Figure 25: Protein mass concentration [mg/ml] in young, middle-aged and old untreated 
rats. The protein content of serum and liver tissue is nearly equal in the different age groups. 
There is no significant difference calculated between the age groups using statistical analysis. 
Values are represented as mean ± SD.  
44 
 
3.3.2. Markers for cell damage  
LDH activity assay  
The results of LDH activity assay in serum and liver tissue of young, middle-aged 
and old untreated rats are shown in Figure 26. The graph shows equal activities 
of LDH in serum by comparing different aged rats with higher error bars in the 
middle-aged group. Regarding LDH activity in liver tissue in contrast to serum, 
the present results show a decline from young to middle-aged and significantly 
lower levels in old rats. These differences in LDH activity may be explained by 
underlying influencing factors including grade of exercise and diseases that might 
affect the measured levels. High LDH activities have been documented in 
pathological conditions such as different types of cancer, hemolysis and 
infections (Erez et al., 2014). The results of the present study indicate that LDH 
activity as marker for general cellular damage is not specific for measuring the 
level of oxidative stress injury in the liver. In addition to reduced specificity of LDH, 
display the high error bars difficulties regarding preservation of enzyme activity 
over time and LDH might get inactivated during storage and not displaying the 
actual situation. 
 
Figure 26: LDH activities in serum [U/l] and liver tissue [mU/mg] of young, middle-aged and 
old untreated rats. LDH activity is almost equal in serum of all age groups. The LDH in liver 
tissue shows a decline from young to middle-aged with lowest amount in old rats. *p<0,05 (young 
versus old rats per one-way ANOVA). 
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ALT activity assay  
The results of ALT activity assay in serum of young, middle-aged and old 
untreated rats are shown in Figure 27. In comparison to serum LDH activities 
which stay almost equal in aging, the ALT activities in serum show a clear age-
dependent increase. The old rats have the highest level of ALT activity followed 
by the middle-aged group. The lowest amount of ALT was detected in the serum 
of young rats. The measured ALT activities differ significantly between young, 
middle-aged and old rats that is consistent with the histological findings that 
visualize higher liver damage in old rats compared to young and middle-aged.  
 
Figure 27: ALT activities [U/l] in serum of young, middle-aged and old untreated rats. ALT 
activities in old rats increase significantly compared to young and middle-aged rats. Lowest 
amount of ALT was detected in young rats. ***p<0.01 (young versus old rats per one-way 
ANOVA). 
3.3.3. Lipid peroxidation marker 
MDA assay 
The results of MDA assay in serum and liver tissue of young, middle-aged and 
old untreated rats are shown in Figure 28. The serum concentration of MDA stays 
nearly equal by comparing the different age groups. In the serum of old rats 
slightly increased MDA concentrations are observed. The values in the middle-
aged group show high fluctuations. In the liver tissue the MDA concentration is 
almost similar in every age group and high fluctuations appear in all ages.            
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No clear trend for increased MDA content could be evaluated in serum and liver 
tissue of different aged untreated rats.  
 
Figure 28: c(MDA) in serum [nmol/ml] and liver tissue [nmol/mg] of young, middle-aged 
and old untreated rats. There could be no significant difference calculated between the age 
groups using statistical analysis.  
4-HNE ELISA  
The results of 4-HNE ELISA measured in liver tissue of young, middle-aged and 
old untreated rats are shown in Figure 29. Before measurements were carried 
out different dilutions were tested. The values that fitted best in the standard curve 
were seen by diluting the sample 1:2000. The lowest level of 4-HNE is measured 
in old rats followed by young and with highest amount in the middle-aged group. 
In contrast to the MDA concentrations in liver tissue, the 4-HNE amounts rise 
from young to middle-aged and fall to the lowest amount in old rats. As 4-HNE 
increases in relation to oxidative damage the results do not verify earlier findings. 
The serum levels of 4-HNE could not be measured due to high interference of 
serum proteins that could not be removed using common methods.  
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Figure 29: c(4-HNE) [ng/mg] in liver tissue of young, middle-aged and old untreated rats. 
Lowest level of 4-HNE appears in old rats and there is an increase from young to middle-aged 
rats. There could be no significant difference calculated between the age groups using statistical 
analysis. 
3.4. Serum and liver tissue after the heat stress  
3.4.1. Protein content  
The results of Lowry protein assay of middle-aged and old rats after heat stress 
in serum and liver tissue are shown in Figure 30. The protein content of old rats 
before and after the heat stress is slightly higher compared to the middle-age 
group with higher error bars. By looking at the different points in time after heat 
stress (0 h, 2 h, 6 h, 24 h), the protein content in serum and liver tissue of old and 
middle-age rats is almost similar. The protein mass concentrations are used to 
normalize enzyme activities of LDH and ALT as well as levels of MDA and 4-HNE 
after heat stress at different points in time in liver tissue samples. 
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Figure 30: Protein mass concentration [mg/ml] in serum and liver tissue of untreated and 
heat-stressed middle-aged and old rats. Almost equal protein amounts in serum and liver 
tissue of old and middle-aged rats are shown at different points in time after heat stress (0 h, 2 h, 
6 h, 24 h). There is no significant difference calculated between the age groups and points in time 
using statistical analysis. Values are represented as mean ± SD.  
3.4.2. Markers for cell damage  
LDH assay  
The results of the LDH activity assay in serum of middle-aged and old rats before 
and at four points in time after heat stress are shown in Figure 31. The LDH 
activities in serum of old rats slightly increase directly after heat stress (0 h) and 
decline until the lowest level 6 h after heat stress. 24 h after heat stress is the 
level of LDH activities in old rats nearly the same as in untreated old rats. In the 
middle-aged group the LDH activities first drop directly after the heat stress (0 h) 
and then rise again in 2 h and 6 h until reaching the peak at 24 h after heat stress. 
The mean values for older rats are in all points in time except for 24 h-group 
higher compared to middle-aged rats. The high error bars indicate a great 
variance of values, whereas there is no significant difference between the age 
groups detected. In comparison to the untreated control group, the heat-stressed 
rats reveal no further detectable cell damage measured as higher LDH activity in 
the serum. The results of the LDH activity assay in liver tissue of middle-aged 
and old rats before and at four points in time after heat stress are shown in Figure 
32. In the liver tissue, the heat-stressed middle-aged rats present 2 h after heat 
stress a peak increase of LDH activities followed by a mild decrease until 24 h 
after heat stress. In the old heat-stressed rats the LDH activities rise directly after 
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heat stress (0 h) in comparison to untreated animals and remain at this higher 
level for the following points in time. The total increase of LDH compared to basal 
levels of untreated animals is higher in both age groups after the heat stress. 
However, these findings are only tendencies and no significant differences could 
be calculated using statistical analysis.  
 
Figure 31: LDH activities [U/l] in serum of untreated and heat-stressed middle-aged and 
old rats. LDH activities are higher in old rats compared to middle-aged rats in untreated control 
group as well as after heat stress except for middle-aged at 24 h. There is no significant difference 
calculated between the age groups and points in time using statistical analysis. Values are 
represented as mean ± SD. 
  
Figure 32: LDH activities [mU/mg] in liver tissue of untreated and heat-stressed middle-
aged and old rats. Increase of LDH activities compared to basal levels of untreated animals is 
higher in both age groups after the heat stress with a peak 2 h after heat stress in middle-aged 
rats. There is no significant difference calculated between the age groups and points in time using 
statistical analysis. Values are represented as mean ± SD. 
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ALT activity assay  
The results of the ALT activity assay measured in serum of middle-aged and old 
heat-stressed rats are shown in Figure 33. In accordance with the serum ALT 
activities of untreated rats, the ALT activities after application of heat stress are 
at all points in time higher in old individuals compared to the middle-aged. In the 
old heat-stressed rats ALT activities stay nearly the same until a drop between 6 
h and 24 h after heat stress. The middle-aged group seems to be less affected of 
the heat stress with nearly equal amounts over time in the heat stress experiment. 
 
Figure 33: ALT activities [U/l] in the serum of untreated and heat-stressed middle-aged and 
old rats. ALT activities remain higher in old animals at all points in time compared to their middle-
aged counterparts. There is no significant difference calculated between the age groups and 
points in time using statistical analysis. Values are represented as mean ± SD. 
3.4.3. Lipid peroxidation marker 
MDA assay  
The results of the MDA assay in serum of heat-stressed middle-aged and old rats 
are shown in Figure 34. In accordance with the serum LDH activities after heat 
stress, the MDA concentration in old heat-stressed rats is at all points in time 
higher compared to the middle-aged group and nearly stays at the same level for 
old rats. Middle-aged rats after heat stress show a decrease directly after heat 
stress (0 h) with lowest level of MDA 2 h post heating that increases again 6 h 
and 24 h after heat stress. There are high standard deviations in the old group 
and no significant difference could be calculated using statistical analysis. 
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Figure 34: c(MDA) [nmol/ml] in serum of untreated and heat-stressed middle-aged and old 
rats. Old rats have higher levels of MDA in untreated and all heat-stressed groups. Middle-aged 
rats show a slight decline until 2 h after heat stress and MDA level rises again 6 h and 24 h after 
heat stress. There is no significant difference calculated between the age groups and points in 
time using statistical analysis. Values are represented as mean ± SD. 
The results of the MDA assay in liver tissue of heat-stressed middle-aged and old 
rats are shown in Figure 35. The MDA concentration in liver tissue shows a mild 
decline in both age groups from untreated rats to groups directly after heat stress 
(0 h). During heat stress the level of MDA in liver tissue in old rats rises up to the 
highest amount at 6 h after heating and falls again 24 h after heat stress reaching 
the level of untreated rats. The MDA concentration in middle-aged rats shows no 
tendency to increase after heat stress and stays at similar levels in untreated and 
heat-stressed groups at all points in time after heat stress.  
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Figure 35: c(MDA) [nmol/mg] in liver tissue of untreated and heat-stressed middle-aged 
and old rats.  The level of MDA in liver tissue before and at different points in time after heat 
stress (0 h, 2 h, 6 h, 24 h) stays nearly the same in both age groups with a peak 6 h after heat 
stress in old rats. There is no significant difference calculated between the age groups and points 
in time using statistical analysis. Values are represented as mean ± SD. 
4-HNE ELISA  
The results of the 4-HNE ELISA in liver tissue for untreated and heat-stressed 
middle-aged and old rats are shown in Figure 36. The levels of 4-HNE in both 
age groups are slightly higher after heat stress compared to the untreated group. 
Middle-aged rats have higher levels of 4-HNE in every group and there is a 
constant increase of 4-HNE up to 6 h after heat stress that remains at this higher 
level 24 h after heat stress. Also 4-HNE levels in old rats show this trend to 
increase directly after heat stress with a peak after 2 h and a following decrease 
until nearly reaching the base level of untreated animals 24 h after heat stress. 
Although a tendency becomes visible no significant difference could be 
calculated using statistical analysis due to high standard deviation. The serum 
levels of 4-HNE after heat stress could not be measured due to high interference 
of serum proteins that could not be removed using common methods.  
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Figure 36: c(4-HNE) [ng/mg] in liver tissue of untreated and heat-stressed middle-aged and 
old rats. Both age groups indicate increased levels of 4-HNE after heat stress with a peak at 6h 
for middle-aged and 2 h for old rats. Middle-aged rats remain at higher 4-HNE levels 24 h post-
heating compared to old rats that nearly reach level of untreated group. There is no significant 
difference calculated between the age groups and points in time using statistical analysis. Values 
are represented as mean ± SD.  
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4. Discussion  
Every organism has a stress level tolerance and former research indicates a 
higher vulnerability of older individuals to attacks of reactive oxygen species. 
Different theories and methods have been designed to measure in vivo oxidative 
stress levels and their impact on cellular aging. The aim was to prevent or slow 
down the aging process leading to a longer and healthier life. Nevertheless, there 
is not yet a verifiable method established to inevitably prove that accumulated 
oxidative damage is responsible for the aging process. Numerous former studies 
have shown that macromolecules including proteins, membrane lipids and DNA 
are susceptible to oxidative damage after having been exposed to higher levels 
of oxidative stress with impact on the metabolic pathways of the organism 
resulting in cellular aging (Stadtman, 2001, Holmes et al., 1992, Catalá, 2009). 
This thesis was designed to show age-related differences in oxidative damage 
measured as enzyme activity and lipid peroxidation products in serum and liver 
tissue of different aged male Wistar rats before and after heat stress. The 
question was whether aged individuals have higher levels of oxidative damage 
after heat stress indicating that they are more affected by the heat.  
Summing up, our studies could not prove earlier findings since age-related 
differences in untreated control groups as well as in heat-stressed groups were 
not statistically significant concerning cell damage, liver injury and lipid 
peroxidation. Young and old rats might have the same amount of oxidative stress 
levels and effective protective methods to buffer ROS attacks or the oxidative 
damage could not be visualized in this series of experiments and further modified 
studies are necessary to evaluate the level of age-related oxidative stress. 
4.1. Review of current studies  
The concept of this study was based on the findings of Zhang et al. that proposed 
young rats have an effective protecting system that buffers oxidative damage in 
stressful conditions such as heat stress (Zhang et al., 2003). The previous 
findings suggested that aging in combination with heat stress produces higher 
levels of ROS and induces hepatic injury that increases in vivo oxidative damage 
to lipids and DNA (Zhang et al., 2003). Additionally, the GSH redox system is 
55 
 
affected and ROS strengthen the redox balance towards the pro-oxidant side 
leading to increased oxidative stress levels. The authors of recent studies 
revealed controversial results for lipid peroxidation products as evaluation of the 
amount of oxidative stress that accumulates during the aging process (Cini and 
Moretti, 1995, Barja de Quiroga et al., 1990, Castro et al., 2012).  
On the one hand in accordance to the findings of Zhang et al., studies in heat-
stressed broiler chickens presented elevated levels of plasma and mitochondrial 
MDA measured via TBA-method that indicate a higher level of lipid peroxidation 
and increased oxidative damage to macromolecules after heat stress (Mujahid et 
al., 2007). Increased 4-HNE-adducts were also measured in rat brains using 
immunohistochemistry after ischemic-reperfusion injury that is related to higher 
ROS formation (Yoshino et al., 1997). The clinical relevance of increased MDA 
as a marker for lipid peroxidation was investigated in various oxidative stress-
related diseases that show higher incidence in aged individuals. Elevated MDA 
levels in serum were found in various forms of cancer such as lung and breast 
cancer (Gonenc et al., 2001) as well as gastric cancer (Bakan et al., 2002). 
Patients suffering from Alzheimer’s disease showed higher MDA levels in brain 
tissue compared to healthy individuals (Lovell et al., 1995). In brain tissue of 
patients suffering from Parkinson’s disease accumulation of 4-HNE-protein 
adducts were measured in immunochemical studies (Yoritaka et al., 1996). 
Arteriosclerosis has been found to correlate with increased serum MDA levels 
and decreased antioxidants (Tamer et al., 2002). Also patients suffering from 
congestive heart failure had higher MDA levels in serum compared to the healthy 
control group (Belch et al., 1991, Ide et al., 1999).  
On the other hand, Tian et al. presented results showing that the amount of lipid 
peroxidation measured as MDA content in liver and brain tissue did not differ 
significantly in aged rats (Tian et al., 1998). An explanation might be that oxidative 
damaged lipids in vivo are fast degraded due to efficient repair mechanisms of 
the cell preventing the disturbance of membrane integrity. MDA in vivo was found 
to be oxidized by aldehyde dehydrogenase enzymes into metabolites such as 
malone semialdehyde and acetate and finally into CO2 and H2O (Marnett et al., 
1985, Siu and Draper, 1982). Therefore, the measured MDA levels in our setup 
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might not display the exact in vivo oxidative stress level of animals as MDA is 
further metabolized and escapes the detection. Also Oberley et al. presented no 
significant differences after a two-phase heat stress experiment performed in 
young and old rats in the amount of 4-HNE-protein adducts measured by 
immunohistochemistry after 90 minutes of recovery (Oberley et al., 2008). They 
came to the conclusion that less 4-HNE protein adducts were formed due to 
increased interfering protection mechanisms.  
Studies analyzing lipid peroxidation levels of different strains and sexes of rats 
including male and female Fischer 344, Wistar and Sprague-Dawley rats 
indicated that the amount of lipid peroxidation might differ species- and sex-
dependent. Rikans et al. showed an age-related increase of MDA in liver 
homogenates of male Fischer 344 rats but in female Fischer 344 rats MDA 
decreased during aging (Rikans et al., 1991). In former study of Zhang et al. male 
Fischer 344 rats were examined whereas in this study male Wistar rats were used 
since no old rats were available from various distributors in Europe. Therefore, 
the gender as well as strain of rats in animal models need to be considered when 
comparing controversial results. In addition to that tissues from different organs 
such as heart, brain, liver as well as muscle tissue presented varying results for 
lipid peroxidation. Female Sprague-Dawley rats exposed to exercise stress that 
was found to increase oxidative stress levels showed elevated MDA levels in 
liver, heart and muscle tissue after acute exercise whereas chronic exercise 
reduces MDA content in brain tissue (Liu et al., 2000). Perez et al. examined lung 
tissue of young (8 months) and old (27 months) male Wistar rats using TBA-
Method with no significant change in MDA level in the old group (Péréz et al., 
1991). Further studies performed by Barja et al. in liver and brain tissue of young 
(8 months) and old male (27 months) Wistar rats also showed no age-dependent 
difference in old rats (Barja de Quiroga et al., 1990). Further studies are 
necessary to establish an animal model that evaluates the oxidative stress level 
identifying differences in strains, genders and tissues of rats.  
The histological evaluation of liver section in accordance to the increased ALT 
activities indicates a higher grade of hepatocellular damage in older individuals. 
Such morphological changes are often accompanied by increased oxidative 
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stress markers including lipid peroxidation products and oxidized DNA. MDA is 
known to be mutagenic and reacts with DNA forming MDA-DNA adducts via 
cross-links that hinder DNA replication and damage DNA in form of DNA strand 
breaks and mutations (Niedernhofer et al., 2003). Former studies of Draper et al. 
showed that higher concentrations of MDA-DNA adducts occur in liver and kidney 
tissue but not in testes of old rats (25 months) compared to young (4 months) rats 
(Draper et al., 1995). This theory is underlined by findings that DNA repair 
mechanisms might slow down during aging leading to the accumulation of DNA 
mutations with more dysfunctional cells. Intano et al. presented that in 
hepatocytes of old mice DNA base excision repair mechanisms decrease up to 
50% compared to young mice (Intano et al., 2003). The accumulation of oxidative 
DNA damage was observed by Hamilton et al. that reported significant increased 
oxidative DNA damage in liver tissue of aged mice as well as senescent Fischer 
344 rats (Hamilton et al., 2001). They compared several tissues of Fischer 344 
rats with different mice strains leading to the conclusion that the amount of age-
related accumulated oxidative DNA damage is tissue- as well as strain- 
dependent. In general, more DNA damage was found in heart and brain tissue 
compared to liver tissue and Fischer 344 rats showed overall a higher increase. 
However, in contrast to the findings of Intano et al. they suggested that a higher 
sensitivity towards ROS attacks is responsible for the accumulation of oxidized 
DNA during aging and to a lesser degree deficient repair mechanisms.  
Another possible explanation for not significantly age-related increased levels of 
liver damage and oxidative stress markers in this setting might be the ability of 
the liver to adapt to increased stress levels as well as efficient protection 
mechanisms that prevent cell damage. The liver is known for its high ability to 
regenerate after injury which is reduced during aging of an organism. A loss of 
regenerative capacity up to 30% in old rats was observed in rodents after 
removing two-thirds of liver tissue also called partial hepatectomy (Timchenko, 
2009). Nevertheless, numerous studies showed protective effects in form of 
preconditioning in the liver. Preconditioning is defined as preadaptation to mild 
levels of stress that partly reduce the grade of severe injury when confronted to 
high and continuous levels of stress. Two forms of liver preconditioning are 
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distinguished: early preconditioning within minutes after stimulus and late 
preconditioning after 12-24 h (Carini and Albano, 2003). In our setting, the liver 
might be preconditioned for increased temperatures after exposure to the first 
heat stress and therefore the second heat impulse 24 h later is weakened. 
Beneficial effects of liver preconditioning such as reduced ischemic-reperfusion 
injury and improved liver regeneration were shown in animal models after partial 
hepatectomy and liver transplantation (Fernandez et al., 2003, Bedirli et al., 
2005). In general, liver preconditioning is observed after short phases of mild 
ischemia or hyperthermia prior to actual liver surgery (Yamada et al., 2001, Oba 
et al., 2010). The ischemic preconditioning (IPC) is defined as a short period of 
ischemia followed by slight reperfusion of the organ prior to the unavoidable long 
ischemia during liver surgery (Wang et al., 2013). Peralta et al. presented that 
aminotransaminase levels (AST and ALT) in rat serum were reduced after 10 
minutes of liver ischemia followed by 10 minutes of reperfusion prior to 
continuous ischemia (Peralta et al., 1999, Tsuyama et al., 2000). The first study 
that demonstrates these protective effects of IPC in the human liver was designed 
by Clavien et al. (Clavien et al., 2000). The ischemic-reperfusion injury is clinically 
relevant as it often occurs during liver surgery when the common Pringle 
maneuver is applied including the temporary occlusion of portal vein and hepatic 
artery to prevent major bleeding for resection of liver tissue (Selzner et al., 1999). 
Different studies presented that decreased levels of aminotransferases (AST and 
ALT) as well as reduced caspase activities displaying fewer apoptosis are found 
after IPC of the liver (Clavien et al., 2000, Glanemann et al., 2004). To understand 
the underlying processes of IPC two different mechanisms are considered. First 
the short period of ischemia at the beginning might directly interfere with signaling 
pathways induced by cell damage and prevent more severe damage. Second the 
sublethal stress during ischemia is essential for the adaptation of the liver to build 
up a defense mechanism that enables the liver later to be more effective against 
high levels of stress (Rüdiger et al., 2003). It is further hypothesized that the 
protection generated by IPC is a form of positive oxidative stress mediated by a 
short sublethal release of oxygen radicals that activate protection mechanisms in 
the cell (Sindram et al., 2002). 
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Another form of liver preconditioning is the heat stress preconditioning (HPC). It 
was performed as sublethal heating before ischemia followed by reperfusion in 
rat livers (Saad et al., 1995, Yamagami et al., 1998). Recent studies showed 
positive effects of heat shock pretreatment on different organs such as reduced 
ischemic-reperfusion injury in rabbit hearts and rat kidneys (Currie et al., 1993, 
Stokes et al., 1996), reduced damage of rat retina after light injury (Barbe et al., 
1988) and protection against sepsis-induced injury in humans (Bruemmer-Smith 
et al., 2001). Different mechanisms take place in an organism when confronted 
to elevated temperatures. Among these is the ability to upregulate the production 
of heat shock proteins (HSP) that serve as protection in hyperthermic conditions 
by decreasing irreversible cell damage (Li et al., 2013). It is proposed that cells 
with the ability to highly upregulate HSP production react more efficiently to 
oxidative stress in form of heating. Early studies about HSP in vitro showed 
species-dependent differences in temperatures that are needed to trigger the 
induction of HSP varying from 45°C in sheep to rodents and humans where 
temperatures between 41°C and 43°C suffice to elevate HSP synthesis (Polla, 
1988). Saad et al. and Kume et al. observed that heat shock prior to ischemic 
liver injury in rats increases gene expression and synthesis of HSP72 and 
reduces severe hepatocellular damage indicated by decreasing ALT and LDH 
activities in serum (Saad et al., 1995, Kume et al., 1996). Further Yamamoto et 
al. investigated the effect of heat shock preconditioning on HSP72 induction and 
liver injury focusing on lipid peroxidation and presented increased levels of MDA 
measured via TBA-method in preconditioned rats but declined amounts of 4-
HNE-protein adducts (Yamamoto et al., 2000). They concluded that lipid 
peroxidation seems to remain unaffected from increased levels of HSP72 but the 
denaturation of proteins induced by LPO product 4-HNE is reduced leading to 
decreased oxidative damage rather than prevention of the LPO process. HSP 
might interfere with the specific antibody making it unable to detect 4-HNE in the 
ELISA. In accordance to these findings, Yamagami et al. confirmed the 
upregulation of HSP72 production in liver tissue of heat shock preconditioned rats 
as well as decreased formation of 4-HNE-protein adducts and reduced ALT and 
LDH activities after ischemic-reperfusion injury (Yamagami et al., 1998). Also 
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decreased ALT and LDH activities as well as higher survival rates were observed 
after heat shock prior to warm ischemia in form of Pringle maneuver and 
correlated to higher amounts of HSP in comparison to the control group (Saad et 
al., 1995). Another approach presented by Oba et al. combined exposure to heat 
shock with application of mild electric current that leaded to higher HSP72 
production, decreased aminotransaminase activities (AST and ALT) and less 
histologically evaluated hepatic injury (Oba et al., 2010). These results support 
the theory that there is a strong protective function of HSP induced by heat stress 
preconditioning of the liver against ischemic hepatic injury finally reducing the 
amount of oxidative liver injury.  
The two-phase heat stress was utilized in this study to simulate heat stress 
conditions of elderly humans during heat waves with multiple periods of heating 
(Bloomer et al., 2014). Especially in heat wave conditions the body is exposed to 
multiple following periods of heat stress and there is a significantly increased rate 
of mortality in people older than 65 years emphasizing the importance of heat 
stress in aging (Kenney et al., 2014, Conti et al., 2005). Heat stress shifts the 
redox balance towards oxidative stress by enhancing ROS production and 
weakening the mitochondrial antioxidant defense system (Slimen et al., 2014). 
This leads to the assumption that heat stress preconditioning might reduce 
hepatocellular damage and therefore in this study the expected increase of 
oxidative damage in the liver of aging rats after heat stress was weakened by the 
first heat stress and could not be measured. 
By evaluating possible pathways for liver damage increased activation of 
caspases was found to increase apoptosis leading to a loss of liver tissue. Cursio 
et al. observed that inhibition of caspase activity protects rats from lethal liver 
damage normally occurring 12-24 h after surgery (Cursio et al., 1999). Other 
studies showed that apoptosis measured via caspase activity is modulated by 
induction of HSP during chronic heat stress in mice and there is correlation 
between HSP levels and heat-induced liver injury (Li et al., 2013). 
Although the possibility of preconditioning after the first heat stress could not be 
excluded as discussed above, different studies indicated that heat stress models 
with two heat shocks induce higher rates of oxidative damage and reduce the 
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tolerance towards heating in old rats compared to single heat stress (Hall et al., 
2000, Kregel et al., 1990). The use of animal models instead of human heating 
experiments is reasonable due to higher target temperatures in animals up to life 
threatening high levels. In animals core temperatures could be raised up to 41 °C 
with control of surrounding conditions such as level of exercise and loss of fluid 
whereas in vivo human heating experiments achieved only mild hyperthermia 
(37-38°C) (Armstrong and Kenney, 1993, Pandolf et al., 1988).  
4.2. Limitations of methods 
Restrictions of the methods used in our study need to be mentioned for the 
correct interpretation of the results that lay the basis for further research in this 
field. The amount of lipid peroxidation product MDA was measured applying the 
TBA-method that is based on the reaction of MDA with thiobarbituric acid (TBA) 
forming MDA-TBA adducts. These MDA-TBA adducts could be measured 
photometrically but the results display all substances that are reactive with TBA 
(TBARS). Therefore, the actual amount of MDA in the sample is higher when 
measured via TBA-method due to other TBA-adducts (Dalle-Donne et al., 2006). 
In addition to that, the heating and acidic conditions in vitro during the assay are 
prone to produce additional oxidative products (Del Rio et al., 2005, Seljeskog et 
al., 2006). The results of the MDA assay using TBA-method should be analyzed 
carefully because the results are often overestimated not displaying the actual 
amount of MDA in the sample. Other detection methods of MDA in serum and 
tissue samples were discussed in former studies. The combination of high 
performance liquid chromatography (HPLC) with the TBA-method was applied to 
receive more exact values for MDA-TBA adducts in samples without further 
generating in vitro oxidative products (Janero, 1990, Fukunaga et al., 1995, 
Mateos et al., 2005). The HPLC method increased the specificity of MDA 
measurements but components in serum were found to interfere and they had to 
be removed beforehand finally artificially reducing the MDA levels (Agarwal and 
Chase, 2002). Newer methods presented the quantification of MDA by using gas 
chromatography (GC) coupled with mass spectrometry (MS) that could be 
performed at room temperature with a two to six times higher sensitivity 
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compared to the common TBA-method (Liu et al., 1997). Although the 
derivatization of samples is needed prior to GC-MS that alters the structure of 
molecules, the newer methods have a higher specificity compared to the common 
TBA-Method but their use is still limited as they are more expensive, time-
consuming and require experts for performing the procedure (Del Rio et al., 
2005). Therefore, the TBA based test is still widely used and offers a facile 
sensitive method to compare MDA amounts when results are carefully interpreted 
(Carbonneau et al., 1991). As MDA reacts with DNA molecules forming MDA-
DNA adducts, the measurement of oxidized DNA molecules in serum and tissue 
indicating increased oxidative stress will more closely replicate the in vivo 
accumulated oxidative damage.  
For the detection of 4-HNE, an aldehyde discovered after MDA as stable end-
product of lipid peroxidation, different methods were presented in former studies. 
Immunoassays such as the sandwich ELISA method use the high reactivity of 4-
HNE to macromolecules to measure the amount of 4-HNE in tissue samples by 
adding specific antibodies that recognize and trap 4-HNE (Borovic et al., 2006). 
Other methods such as HPLC or GC-MS directly detect 4-HNE but due to its high 
reactivity the major amount of free 4-HNE is bound in 4-HNE-adducts and 
escapes direct measuring (Spickett, 2013). For the evaluation of 4-HNE in liver 
tissue in addition to the ELISA assay, the immunohistochemical staining of 4-
HNE based on the theory of 4-HNE accumulation in hepatocytes might visualize 
more clearly higher levels of lipid peroxidation in older rats. Haak et al. presented 
that the amount of 4-HNE in mitochondria of liver tissue measured via 
immunoblotting technique significantly increased after a two-phase heat stress 
experiment in young and old male Fischer 344 rats at 24 h after the second 
heating leading to the conclusion that oxidative damage appears to a greater 
extend (Haak et al., 2009). 
The determination of enzyme activity in serum and tissue samples might be 
affected by repeated freeze-thaw cycles that could reduce enzyme activities. 
Therefore, the results of LDH and ALT activity assays performed in this study 
might be affected as enzymes are inactivated and therefore no significant 
difference could be displayed. Finally, the possibility of preconditioning after the 
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first heat stress needs to be further examined by comparing different heat stress 
experiments. The following questions for researchers include how the heat stress 
upregulates age-depending protection mechanisms and whether HSP play a role 
for protecting tissues in heat stress conditions.  
4.3. Conclusion 
Our data showed controversial results concerning the heat stress experiment to 
the earlier findings of Zhang et al. and therefore three main aspects need 
consideration in following studies: a) role of preconditioning in two-phase heat 
stress experiments, b) if other organs are affected by oxidative injury, c) role of 
antioxidative protection. This thesis was a first approach to identify useful 
biomarkers that display age-related in vivo oxidative stress levels by analyzing 
the effect of heat stress on different aged rats. Further investigations will be 
necessary to evaluate the level of oxidative damage in heat stress experiments 
with altered settings including one- and two-phase heat stresses. Studies showed 
that lipid peroxidation products differ between sexes and strains of animals and 
therefore might also vary in humans. In addition to that, the identification of 
protection mechanisms in form of antioxidants is essential to prevent oxidative 
stress damage. Antioxidative substances including vitamin E and quercetin were 
investigated in various studies for their protective function. Vitamin E was found 
to inhibit lipid peroxidation in rat liver microsomes (Pulla Reddy and Lokesh, 
1992). Quercetin a plant-derived substance contained in different foods was 
found to protect rat livers against injury caused by sodium fluoride-induced 
(Nabavi et al., 2012) as well as alcohol-induced oxidative stress (Liu et al., 2010). 
An antioxidative substance that efficiently reduces oxidative damage from ROS 
attacks and still enables proper cell signaling might contribute essentially to the 
control of oxidative stress and the prevention of cellular aging. As the liver has a 
high regenerative capacity, it might be not as affected by oxidative tissue injury 
as e.g., nerve or brain tissue of the central nervous system. In different 
neurodegenerative diseases, higher levels of lipid peroxidation products were 
measured that support this hypothesis. Especially age-dependent diseases such 
as Alzheimer’s disease and Parkinson’s disease clearly indicate a correlation to 
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oxidative stress injury. Age-related differences in stress response, oxidative 
damage and protection mechanisms might be seen by comparing brain tissue of 
healthy elderly with patients suffering from neurodegenerative diseases. Newer 
approaches for in vivo studies of oxidative stress observing the effect of caloric 
restriction (CR) presented interesting results. Researchers showed extended life 
spans for different species and reduced oxidative DNA damage in CR animal 
models. Species-dependent extended life spans after CR were studied in yeast 
Saccharomyces cerevisiae, the fruit fly Drosophila melanogaster and mice 
(Gems and Partridge, 2013). In theory, the caloric restriction leads to decreased 
metabolic rate and lower body temperature due to less energy metabolism that 
leads to fewer oxygen processing in mitochondria with decreased formation of 
ROS and therefore is thought to reduce the oxidative damage (McCarter et al., 
1985). Hamilton et al. showed that CR significantly reduces age-related 
accumulation of oxidative damage DNA in rodents (Hamilton et al., 2001). Sohal 
et al. discovered that CR alters the age-related production of O2-• and H2O2 and 
weakens further accumulation of oxidative damage (Sohal et al., 1994a, Sohal et 
al., 1994b). CR further reduced the loss of membrane fluidity seen in older rats 
(Chen and Yu, 1994). Future animal models designed for examination of in vivo 
age-related effects of heat stress should include caloric restriction and further 
observe whether caloric intake influences accumulation of oxidative damage.  
Our study serves as a window for the understanding of oxidative stress-induced 
damage as well as age-related deterioration caused by accumulated damage 
over time. On balance, further studies are needed to establish useful animal 
models that could be transferred to humans. The next steps following are the 
regulation of cellular aging without increased susceptibility to diseases or even 
the prevention of aging processes to enable the human being to live a healthy life 
within its maximum life span.  
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5. Abstract 
Aging of an organism is defined as progressive decline of physiological functions 
with increased probability for disease and death within the life span. Increased 
production of reactive oxygen species (ROS) combined with a reduced capability 
of protection in form of antioxidants represents oxidative stress that is thought to 
be a major contributor to cellular aging. This study is integrated in the joint 
research project OXISYS of the Federal Ministry of Education and Research 
(BMBF) and investigates age-related changes of enzyme activity, liver damage 
and oxidative stress before and after a two-step heat stress experiment in serum 
and liver tissue of different aged male Wistar rats. Young (7 weeks, N = 8), 
middle-aged (6/7 months, N = 10) and old (23 months, N = 10) rats were included 
in the control group without treatment. The heat-stressed group was divided into 
middle-aged (7 months, N = 22) and old (23 months, N = 22) rats liquidated at 
four points in time after the second heat stress (0 h, 2 h, 4 h, and 6 h). Based on 
former findings of Zhang et al., lactate dehydrogenase (LDH) activity indicating 
general cellular damage as well as alanine-aminotransferase (ALT) activity 
specifically monitoring liver damage were measured. As oxidative stress affects 
macromolecules such as proteins, DNA and lipids, two lipid peroxidation end-
products, malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) were 
analyzed in the samples. Hematoxylin & Eosin Staining of liver sections was 
performed to histologically evaluate hepatocellular damage. Our data shows that 
the expected increase of enzyme activity and lipid peroxidation markers before 
and after the heat stress could not be significantly verified in this setup. 
Histological liver damage appeared more severe in older rats whereas the liver 
morphology in young rats was normal. Controversial results of oxidative stress in 
animal models after heating lead to the hypothesis that age-related oxidative 
damage in the liver is less in comparison to other organs. The role of precondition 
after the first heat stress due to high regenerative capacity of the liver needs to 
be further investigated. To finally understand the molecular pathways of oxidative 
stress in aging, the analysis of protection mechanisms in form of enzymatic and 
non-enzymatic antioxidative protection is necessary. Further research in the field 
of oxidative stress is essential to finally encode the mystery of cellular aging. 
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6. Zusammenfassung 
Das Altern ist definiert als ein fortschreitender Prozess begleitet von konstanter 
Abnahme der physiologischen Eigenschaften eines Organismus, der im Laufe 
der Zeit zu Krankheit und letztendlich unweigerlich zum Tode führt. Als eine der 
Hauptursachen für den zellulären Alterungsprozess wurde eine erhöhte 
Zellschädigung durch vermehrten oxidativen Stress entdeckt, die definiert ist als 
Ungleichgewicht zwischen zunehmender Freisetzung reaktiver 
Sauerstoffspezies (ROS) und dem Abfall protektiver Antioxidantien. Diese Studie 
ist ein Bestandteil des über das Bundesministerium für Bildung und Forschung 
geförderten Verbundprojektes OXISYS und untersucht altersabhängige 
Zellschäden vor und nach einem zweiphasigen Hitzestressversuch in Serum und 
Lebergeweben von männlichen Wistar-Ratten in verschiedenen Altersgruppen. 
Die Kontrollgruppe ohne Hitzestressbehandlung besteht aus jungen (7 Wochen, 
N = 8), mittelalten (6/7 Monate, N = 10) und alten (23 Monate, N = 10) Ratten. Im 
Hitzestressversuch wurden mittelalte (7 Monate, N = 22) mit alten (23 Monate, N 
= 22) Ratten verglichen und die Probenentnahme sowie die Liquidation erfolgte 
an vier verschiedenen Zeitpunkten (0 h, 2 h, 4 h, 6 h) nach dem zweiten 
Hitzestress je Altersgruppe. Basierend auf Vorstudien von Zhang et al wurden 
die generelle Zellschädigung mittels Lactatdehydrogenase (LDH)-Aktivität und 
die spezifische Leberschädigung zusätzlich anhand der Alaninaminotransferase 
(ALT)-Aktivität bestimmt. Oxidative Schäden an zellulären Bestandteilen wie 
Proteinen, DNA und Fetten akkumulieren im Alter und es wurden zwei 
Endprodukte der Lipidperoxidation, Malondialdehyd (MDA) und                                  
4-Hydroxynonenal (4-HNE) bestimmt, um den Grad des oxidativen Stresses zu 
verdeutlichen. Ergänzend wurde die Leberzellschädigung durch histologische 
Beurteilung Hämatoxylin & Eosin eingefärbter Schnitte von Lebergewebe 
dargestellt. Die Untersuchungen dieser Studie zeigten ein Ausbleiben des 
erwarteten signifikanten Anstieges der Enzymaktivitäten und Markern der 
Lipidperoxidation vor und nach Hitzestress in älteren Ratten. Histologisch konnte 
eine höhere Leberzellschädigung in alten Ratten im Vergleich zu weitgehend 
normalem Lebergewebe in jungen Ratten gezeigt werden. Kontroverse 
Ergebnisse im Tiermodell nach Hitzestress könnten eine geringere 
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Beeinträchtigung der Leber im Vergleich zu anderen Organen nahelegen. 
Besonders aufgrund der hohen Regenerationsfähigkeit der Leber sollte die 
Möglichkeit einer Präkonditionierung in dieser Untersuchung nach dem ersten 
Hitzestress in Betracht gezogen werden. Dazu kommt die mögliche Rolle 
protektiver Antioxidantien, die in weiteren Studien zusätzlich untersucht und 
ebenfalls miteinbezogen werden sollte. Eine endgültige Entschlüsselung des 
menschlichen Alterungsprozesses ist weiterhin grundlegender Bestandteil der 
molekularen Alterungsforschung und weitere Untersuchungen sind notwendig 
um effektive Gegenmaßnahmen zu entwickeln und dem Menschen ein langes 
gesundes Leben zu ermöglichen. 
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8. Appendix 
Table 7: Protein content, LDH, ALT and MDA in human serum for preliminary experiments. 
Values are represented as mean ± SD. ***p<0.01 (young vs. old group), ns (not significant).  
 Young people Old patients 
Number  8 8 
Mean age [Years] 26.75 71.75 
Male [m] or female [w] 4 m + 4 w 4 m + 4 w 
Protein mass concentration [mg/ml] 84.89 ± 13.05 71.11 ± 7.16 (ns) 
LDH activity serum [U/L] 36.82 ± 14.38 67.74 ± 13.54 (***p<0.01) 
ALT activity serum [U/L] 13.72 ± 9.50 26.47 ± 19.17 (ns) 
MDA serum [nmol/ml] 4.02 ± 1.04 5.20 ± 1.41 (ns) 
 
Table 8: Protein content, LDH, ALT, MDA and 4-HNE in serum and liver tissue of young, 
middle-aged and old untreated rats. Values are represented as mean ± SD. *p<0.05 (young 
vs. old group), ***p<0.01 (young vs. old group), ns (not significant).  
 
Young  Middle-aged  Old 
Protein content 
serum [mg/ml] 
22.09 ± 6.07 (N = 8) 27.13 ± 9.23 (N = 10, ns) 29.56 ± 5.67 (N = 10, ns) 
Protein content liver 
tissue [mg/ml] 
31.44 ± 7.61 (N = 8) 30.57 ± 6.52 (N = 10, ns) 30.89 ± 2.60 (N = 10, ns) 
LDH activity serum 
[U/L] 
66.13 ± 26.39 (N = 8) 83.60 ± 39.29 (N = 9, ns) 77.71 ± 33.37 (N = 9, ns) 
LDH activity liver 
tissue [mU/mg] 
8.58 ± 2.39 (N = 8) 7.64 ± 2.24 (N = 10, ns) 6.96 ± 2.49 (N = 7, 
*p<0.05) 
ALT activity serum 
[U/L] 
6.83 ± 3.89 (N = 8) 
 
10.68 ± 0.93 (N = 9, ns) 
 
15.85 ± 5.92 (N = 9, 
***p<0.01) 
MDA serum 
[nmol/ml] 
9.39 ± 1.14 (N = 7) 10.28 ± 4.29 (N = 10, ns) 10.41 ± 1.13 (N = 10, ns) 
MDA liver tissue 
[nmol/mg protein] 
0.38 ± 0.13 (N = 8) 0.43 ± 0.11 (N = 10, ns) 0.40 ± 0.1 (N = 10, ns) 
4-HNE ELISA liver 
tissue [ng/ml] 
0.52 ± 0.07 (N = 8) 0.57 ± 0.17 (N = 9, ns) 0.42 ± 0.1 (N = 8, ns) 
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Table 9: Protein content, LDH, ALT, MDA and 4-HNE in serum and liver tissue of middle-
aged heat-stressed rats at four points in time. Values are represented as mean ± SD. There 
is no significant difference calculated between the age groups and points in time. 
Middle-aged 0 h (N = 6) 2 h (N = 6) 6 h (N = 6) 24 h (N = 4) 
Protein content 
[mg/ml] serum 
29.51 ± 4.29 27.04 ± 5.93 25.46 ± 2.72 25.07 ± 3.02 
Protein content 
[mg/ml] liver tissue 
32.02 ± 3.53 29.47 ± 4.73 31.12 ± 5.22 26.01 ± 2.11 
LDH serum [U/L] 54.26 ± 27.71 72.65 ± 31.12 62.33 ± 16.22 99.74 ± 51.19 
LDH liver tissue 
[mU/mg] 
7.24 ± 1.62 10.65 ± 2.17 9.18 ± 2.87 9.94 ± 0.49 
ALT serum [U/L] 12.11 ± 2.96 10.95 ± 3.44 9.90 ± 2.41 11.67 ± 5.34 
MDA serum [nmol/ml] 8.38 ± 1.47 7.42 ± 1.59 8.66 ± 1.41 8.98 ± 0.18 
MDA liver tissue 
[nmol/mg protein] 
0.39 ± 0.07 0.40 ± 0.10 0.39 ± 0.14 0.41 ± 0.13 
4-HNE liver tissue 
[ng/ml] 
0.59 ± 0.11 0.60 ± 0.08 0.82 ± 0.38 0.83 ± 0.16 
 
Table 10: Protein content, LDH, ALT, MDA and 4-HNE in serum and liver tissue of old heat-
stressed rats at four points in time. Values are represented as mean ± SD. There is no 
significant difference calculated between the age groups and points in time. 
Old 0 h (N = 6) 2 h (N = 6) 6 h (N = 6) 24 h (N = 4) 
Protein content 
[mg/ml] serum 
31.57 ± 6.78 32.41 ± 11.07 30.46 ± 9.57 25.95 ± 5.57 
Protein content 
[mg/ml] liver tissue 
31.46 ± 5.48 31.19 ± 6.41 28.93 ± 8.28 28.86 ± 6.08 
LDH serum [U/L] 86.31 ± 34.13 81.22 ± 40.26 75.24 ± 10.00 85.28 ± 26.97 
LDH liver tissue 
[mU/mg] 
8.63 ± 3.96 8.74 ± 2.66 9.15 ± 3.83 8.86 ± 4.88 
ALT serum [U/L] 18.79 ± 8.93 16.97 ± 5.67 16.98 ± 8.37 10.94 ± 8.15 
MDA serum [nmol/ml] 10.96 ± 3.33 11.03 ± 4.14 10.91 ± 2.81 11.62 ± 3.37 
MDA liver tissue 
[nmol/mg protein] 
0.36 ± 0.07 0.41 ± 0.10 0.43 ± 0.14 0.40 ± 0.08 
4-HNE liver tissue 
[ng/ml] 
0.56 ± 0.21 0.63 ± 0.46 0.60 ± 0.21 0.46 ± 0.05 
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Figure 37: Decision tree for measuring oxidant status in clinical tissue. [adopted from 
(Griendling et al., 2016)]. 
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